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 1. INTRODUCTION  
.Siddha system of medicine is one of the oldest therapeutic systems prevalent 
predominantly in southern part of India. Siddha is not only a medical a system; it‟salso 
dealing with intense spirituality and immense possibilities for the betterment of human being. 
Unlike other systems, siddha system aims in both the treatment and prevention of the disease. 
The word Siddha comes from the word „Siddhi‟ which means „An object to be 
attained‟ or „Perfection‟ or „Heavenly bliss‟ or „Eternal bliss.‟ 
To achieve eternal bliss, the physical body alone is the vehicle. But the body is 
transient and is easily susceptible to disease and suffering hence, is unable to attain salvation. 
Therefore, in order to get rid of such suffering and to achieve the threefold benefit, long life 
is essential. 
“The real Holy Scripture is the Great Work on Longevity” 
For “Salvation” is attainable only by mankind 
And as the blessed medicine is extolled 
To protect our physique from mortality” - Theraiyar (1) 
 
For that, to live the healthiest and longest life, our physical function should be 
maintained in a balanced state, which means our three humors that are Vatham, Pitham, 
Kapham, viz., wind, bile, phlegm should be in the ratio of 4: 2: 1 respectively. If there is any 
derangement in these three humors, they bring about diseases peculiar to their influence that 
are classified into 4448 types by Sage Yugimuni. In that, Kalladaippu noi is one among them. 
Based on body humours, it is classified into 4 types likevali kalladaippu, azhal kalladaippu, 
kapha kalladaippu and mukkutra kalladaippu by Sage Yugimuni. In that, the dietary factors 
play an important role in the derangement of pitha kutram. The raised Azhal Kutram dries up 
the body fluid and urine, resulting in concentration of salts. This further affects the Keezh 
Noekku Kaal. One of the functions of Keezh Noekku Kaalis to excrete Urine.So when this 
Keezh Noekku Kaal is affected urine will be obstructed in the urinary tract
 (2)
.This favours the 
deposition of urinary salts to develop into calculi anywhere in the kidney or urinary tract. 
The features mentioned in kalladaippu noi can be compared with urolithiasis mentioned in 
modern medicine. 
Urolithiasisis isone of the commonestdiseases in our country and pains due to kidney 
stones are known as worse than that of labour pain. In India,approximately 5-7 million 
patients suffer from stonedisease and at least 1/1000 of Indian population 
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needshospitalization due to kidney stone disease
(3)
.In India upper and lower urinary tract 
stones occurfrequently but the incidence shows wide regional variation. The incidence of 
renal calculi iscomparatively low in the southern part of countrycompared to other 
parts
(4)
.Even though there are lot of diuretics are available in the allopathic system there are 
some adverse effects are always reported. There is a need for a drug without causing any 
adverse effects. 
           In our Siddha system of medicine besides herbals, metals, minerals and animal 
products has been used to prepare the medicine
(5)
.Medicine cures diseases through bring back 
the deranged kutrams into balanced state and they are classified into two types that are 
internal and external medicine. In that, Kalladaippu Thool
 (6)
is one type of the herbo-mineral 
formulated internal medicine to treat urolithiasis. 
  The ingredients of Kalladaippu Thool are Naayuruvi (Achyranthes aspera),Vaazhai 
charugu(Musa paradaisiaca), Panaipoo(Borasses flabelifer),Katthari(Solanum melogena), 
Katthakaambu(Uncaria gambir), Vengaram(Sodium Biborate),Padigaram(Aluminium 
PottassiumSulphate), Induppu(Sodium Chloride Impurae) and Savukkaaram(Sodium 
Carbonate). In thatNaayuruvi, Vaazhaicharugu, panaipoo said to be effective in Kalladaippu 
as mentioned in Mooligai Marmam.As per the literature review of Gunpadam 
Thathu,Vengaram has lithontriptic and diuretic action andPadigaram, Induppu has diuretic 
action. 
The above said drug formulation has not undergone any preclinical trial so for. Hence 
I have selected the siddha formulation Kalladaippu Thool for evaluating the safety and 
therapeuticeffect through the toxicity study and the following pharmacological studies. 
 
 Anti-Uroliathiatic activity           
 Diuretic activity                         
 Saluretic activity                        
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2. AIM AND OBJECTIVES 
Aim: 
 To evaluate the Safety and pharmacological profile of the test drug “Kalladaippu 
Thool‟‟ (6) in animal model. 
Objectives: 
 Collection of variousinformation (Siddha and modern) relevant to the study 
 Preparation of the drug as per classical Siddha literature 
 Analytical study of  the  prepared drug  
 Physicochemical analysis 
 Chemical analysis 
 X-ray Diffraction Study 
 Toxicity studies  
 Acute oral toxicity study (OECD – 423 Guideline). 
 28 days Repeated oral toxicity study (OECD – 407Guideline). 
 90 days Repeated oral toxicity study (OECD – 408 Guideline). 
 Pharmacological activities in Wister albino rats 
 Anti-Uroliathiatic activity -Ethylene Glycol Induced Method    
 Diuretic activity                 -  Lipschitz method                                                                                                                                                                                                                            
 Saluretic activity                   
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3.1. GUNAPADAM REVIEW 
NAAYURUVI - Achyranthus aspera, Linn.
 
Synonyms: 
 Abamaarki 
 Krishnabanni 
 Saramanjari 
Parts used: 
 Whole plant 
Organoleptic Characters: 
Taste  : Bitter, Astringent, Pungent                                              
Character  : Heat   
Division  : Pungent 
Actions:   
 Astringent 
 Diuretic 
 Alterative (10) 
General characteristics - ஥ானேன௉யி 
ந஬ிகாபங்ககப்ன௃ள்஭அ஧நார்க்கினின்வயபால்யசினன௅ண்டாம் 
இக஬னெ஬உதிபநந்தம்வ஧திக஧ம்யினர்வுதந்தினி஫ங்குவநகம் 
நக஬வனறும்஧டின௃ரினேன௅ள்஭ரிசி஧சுநாற்றும்யச஦னெ஬ம் 
஧஬நாதர்க்குள்஭ழுக்கக஥ீக்குயங்கச்சிந்துபம்஧ண்ணுநாவதா. 
                                           - Theraiyar Gunavagadam 
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It cures bleeding piles, diarrhoea, kapha diseases, excess sweating and leucorrhoea. 
 
Medicinal uses
 (9)
:
 
 Decoction of the whole plant is given for abdominal disorder. 
 Whole plant can be used for the obstruction in the post-partum bleeding. 
 Its root ash powder is mixed with palm jaggery and given orally to conduct normal 
delivery without any complication.  
 Take 15 ml of its juice with some sugar, and drink for four or five days .This will cure 
joint pain, menorrhagia, cough and eczema. 
 Take equal amount ashes of Achyranthes aspera and flower of Borassus flabellifer 
and put them in water and collect the clear water from that top and boil it. A salt will 
be obtained called Nayuruvi Uppu. Giving 2or 3 pinches of salt with ghee or butter 
will cure asthma, ulcer, atrophy of bones and cold. 
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VAAZHAI – Musa paradisiaca 
Synonyms: 
 Kathzhi 
 Saekili 
 Ambanam 
 Arambai 
 Vosai. 
Parts used: 
Leaf, flower, tender vegetable, vegetable, fruit, bark and stem. 
Organoleptic Characters: 
Taste of banana tuber  : Astringent  
Character   : Heat  
Division    : Pungent 
Actionsof Plantain bark: 
 Refrigerant(10)  
General characteristics - யாகம 
யாகம஥ீர்தான்கு஭ிர்ச்சியல்஬஧஬ன௅ண்டாகும் 
வ஧கமயனிறுகடக்கும்ப஧ண்நனிவ஬! - யழீுயல்஬ி 
பத்தக்கிரிச்சபநரி஥ீரிகயனேடவ஦ 
சிற்஫ிபணம்வ஧ாக்குந்பதரி.-Agathiyar Gunavagadam. 
It cures all gastro intestinal disorder. It nourishes our body and improves 
spermatogenesis.
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Medicinal uses
(9)
:
 
 Ash of bark is mixed with water and filtered. Then it is boiled until to get salt which 
has diuretic property. 
 Salt which is obtained by using the ash of Plantain bark, Sesame plant, Palm root, 
Tobacco and Flower plant is used for infantile hepatic problem and cures anemia and 
ascites. 
 35 ml of banana stem juice is given for kidney stone. 
 15 ml of juice is given for snake bite. 
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PANAI POO - Borassus flabellifer, Linn. 
Synonyms:                        
 Thaalam 
 Karumpuram 
 Aedagam 
Parts used: 
Root, flowering stalk,juice,bark and fruit. 
Organoleptic Characters: 
Taste   : Astringent  
Character  : Coolant 
 
Division  : Sweet 
Actions: 
 Astringent 
 Diuretic 
 Nutritive 
 Refrigerant. (10) 
General characteristics- ஧க஦ன௄ 
஧க஦னிலுறுன௄஬துதான்கங்கன௅஫ாக்குன்ந 
யிக஦னகற்றும்஥ீர்கட்கடநீட்டும் - ன௅க஦னா஦ 
஧ன்வ஦ாய்ஒமிக்கும்஧மஞ்சுபத்கதப்வ஧ாக்கியிடும் 
ன௅ன்வ஦இதக஦யி஭ம்ன௃. - Agathiyar gunavagadam.  
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It cures peptic ulcer,burning micturition anddental diseases. 
 
 
Medicinal uses
(9)
:
 
 Drinking about 100 ml of fresh juice everyday morning before sun rise during 
summer will be a useful remedy for tuberculosis, chronic dyspepsia, psoriasis and 
skin diseases. 
 A salt is extracted from ash of the burnt male flower is given for urinary disorders, 
dyspepsia, tooth ache and chronic disorder. 
  The seed pulp of palm is remedy for venereal affection and dysentery. 
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KATTHARI – Solanum melongena 
Synonyms:  
 Vazhuthazhai 
 Vazhithunai 
Parts used:  
Whole plant 
Organoleptic Characters: 
Taste   :          Bitter and Astringent.  
Character  :           Heat 
Division  : Pungent 
Actions:  
 Stimulant 
 Hypnotic 
 Expectorant(1s0) 
General characteristics - கத்தரி 
கத்தரிக்காய்஧ித்தங்க஦ன்஫க஧ந்தீர்த்துயிடும் 
பதாத்தபசா஫ிசிபங்ககத்தூண்டியிடும்பநத்தவுந்தான் 
஧ிஞ்சா஦கத்தரிக்காய்வ஧சுன௅த்வதாடம்வ஧ாக்கும் 
நஞ்சார்குமவ஬!யழுத்து.    - Agathiyar Gunavagadam 
It neutralizes pitham and reduces kapham.Tender brinjal is taken to normalize the 
thridosha. 
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Medicinal uses:
(9) 
 Leaves are added in diuretic type decoction. It helps for good sleep. 
 Katthari can also be taken in food for three times a day. But it never causes any 
illness. It comes under in dietary regimen food (pathiyam in Siddha). 
 Ripped fruits are best for hepatic disease. 
 Burnt fruit improves digestion, but it leads to purgation. 
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KATTHAKAAMBU – Uncaria gambir 
Synonyms:  
 Oothalai maram 
Parts used:  
  Stem 
Organoleptic Characters: 
Taste   :   Bitter, Astringent.  
Character  :    Heat 
Division  :     Pungent 
Actions: 
 Astringent (10) 
General characteristics - கத்தக்காம்ன௃ 
வ஧திசிறு஥ீர்கட்டும்வ஧சபயாணாயாய்யிபணன௅ம் 
தீதிலுனன௉ந்திப்ன௃ண்தீன௉வநவநதி஦ினில் 
பசங்குன௉திவதாசபந஬ாம்தீர்ந்துயிடும்யிந்திறுகும் 
க஧ன்கூந்தல்நாவந஧கார். 
-Siddha Vaithiya Pathaartha Gunavilakkam. 
It cures diarrhea, anuria, oral ulcer, chronic ulcer, and throat ulcer, hoarseness of 
voice and tooth ache.
 
Medicinal uses:
(9) 
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 650-1gm of chooranam is prepared from the mixture of 8 gm powder of 
katthakaambu,Karuvaapattaiand 2 gm powder of Saathikai thool is taken along 
with honey to cure diarrhoea. 
 
VENGARAM – Borax (Sodium Biborate) 
It is composed of boric acid and soda. 
Synonyms:  
 Porikaram 
 Karam 
 Urukkumithiran 
 Danganam 
 Thoomathaiyadakki 
Organoleptic Characters: 
Taste     : Sweet mixed with astringent 
Character : Heat 
Division : Coolant 
Actions:
(8)
 
 Diuretic 
 Astringent 
 Lithodialysis 
 Emmenogogue 
General Characteristics - பயங்காபம் 
பசா஫ின௃கடபனண்குன்ந஥கநவசாரினாசம் 
஧஫ிகிபகணிகல்லூ஦ம்஧ன்வ஦ாய்ப஥஫ிகனத் 
தடங்கணங்க஧ங்கின௉நிசர்ப்஧யிடஞ்சந்஥ி 
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னிடங்கணங்க஬க்கிற்வ஧ாபநண்.  -SiddhaMateria Medica 
It cures urinary calculus, burning micturition, worm‟s infection, hemorrhoids, 
hemiplegia, urinary tract infections, abdominal diseases and venereal ulcer with pus. 
PADIGARAM- Alum (Aluminium Potassium Sulphate) 
It is colorless, transparent crystals with acid. Alum is a general name for a classof 
double sulphates containing aluminium and such metals as potassium, ammonium, iron etc. 
Synonyms: 
 Cheenam 
 Padigi 
Organoleptic Characters: 
Taste    : Sweetish astringent 
Potency : Heat 
Division  : Pungent 
Actions: 
(8)
 
 Astringent 
 Diuretic 
 Hemostatic 
 Antispasmodic 
General Characteristics- ஧டிகாபம்  
சீ஦பநனும்காபநதுசீ஫ியன௉஧ல்஬பகண 
ஆக஦க்கால்கண்வணாய்அ஦ி஬பநாடுநா஥ி஬த்தில் 
துன்நாங்கிசம்யானேவதா஬ாதஉள்஭மக஬ 
குன்நநிகயவ஧ாக்குபந஦க்கூறு.            - Siddha Materia Medica 
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It cures gingivitis,  eye diseases, elephantiasis, vayu tumour,  sense of heat, gastric 
ulcer,  hypertension,  hemorrhage,  dysentery,  diarrhoea,  children‟s vomiting, whooping 
cough with expectorant,  pharyngitis,  menorrhagia and gonorrhoea. 
 
INDUPPU – Rock Salt (Impure Sodium Chloride) 
Synonyms: 
 Cynthavam 
 Chindooram 
 Chandiranuppu 
 Mathikoormai 
 Mathiuppu 
 Minthachol 
Organoleptic charaters: 
Taste   :  Salt 
Potency       :  Heat 
Division :  Pungent 
Actions: 
(8)
 
 Diuretic 
 Laxative 
 Carminative 
General Characteristics - இந்துப்பு 
அட்டகுன்மமந்தம்அசிர்க்கரஞ்சூர்சதீபித்தந் 
துட்டவையம்நாடிப்புண்டடாடங்கள்ககட்டமலக் 
கட்டுைிடைிந்வதயக்காமியடநாய்ைன்கரப்பான் 
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ைிட்டுைிடைிந்துப்வபைிள்.          -  Siddha Materia Medica 
It cures eight types of gastric ulcer, indigestion, blood diseases,kaphathikkam,syphilis, 
derangement of three humours, constipation, poison‟s bite, spermatorrhoea, cataract, 
hemorrhoids and vatha pain 
. 
SAVUKKARAM-Sulphate of soda(Sodium Carbonate) 
General Characteristics–சவுக்காபம் 
தீனசவுக்காபஞ்பசப்ன௃வயன்வகல௃  
நானாதின௄஦ரீ்யார்பயடிச்சாபன௅ந் 
வதாய்பயடி஥ீரிற்சுண்டிடக்காய்ச்சி 
யானைபபனண்கணயடித்துஉன௉ட்டிவட 
உன௉ட்டினகாபம்ஓம்சவுக்காபன௅ம் 
நன௉ட்டிடுஞ்சபக்ககயாட்டிபனடுத்திடு 
தின௉ட்டுகள்வ஧சிதிரிகி஫யாதிகன 
பநன௉ட்டுநிக்காபம்வயகதகள்வகாடிவன. 
- நச்சன௅஦ி 800 ஧க்கம் 24 
சவுக்காபம்: 
கார்வநகத்துர்ப்஧கடனேம்கட்டிக்கபப்஧னுடன் 
கார்வநகவூ஫ற்஫ழு஧஬ன௉ம்வசர்வநகத் 
பதாட்டியன௉ம்஥கத்தினூ஫யகற்஫ியிடும் 
கட்டிச்சவுக்காபங்காண். 
- சித்தகயத்தின஧தார்த்தகுணயி஭க்கம் 
It is useful in dyspepsia with vomiting, diarrhoea and flatulence. 
17 
 
 
 
 
 
3.2. BOTANICAL REVIEW 
Achyranthes aspera linn, 
Common name: 
 Flower plant 
Vernacular names: 
 Tamil  : Sirukadaladi 
 Hindi : Latjira, Chirchira 
 Telugu  : Uttaraena 
 Gujarati  : SafadAghedo 
  Malayalam : Kadaladi 
 Unani : Chirchitaa 
 Sanskrit : Aghata 
Taxonomicalclassification :
( 16) 
Kingdom  : Plantae 
Subkingdom : Tracheobinota 
Super Division : Spermatophyta 
Division   : Magnoliophyta 
Class   : Magnoliopsida 
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Sub Class  : Caryophyllidae 
Order   : Caryophyllales 
Family   : Amaranthaceae 
Genus   : Achyranthes 
Species  : aspera   
Parts used: 
 Whole plant 
Phytochemicalconstituents :
( 11) 
 Saponins 
 Ecdysterone 
 Oleonolicacid 
 Dihydroxy ketones 
 Long chain compounds 
 Alkaloids 
Actions: 
 Spermicidal activity 
 Anti-parasitic activity 
 Astringent activity 
 Hypoglycemic activity 
 Cancer chemo preventive activity 
 Hepatoprotective activity 
 Antimicrobial activity 
 Anti-oxidant activity 
 Anti-allergic activity 
 Wound healing activity 
19 
 
 Immunomodulatory activity 
 Cancer Chemo preventive activity  
 Nephroprotective activity. 
 
 
 
MedicinalUses :
( 11) 
 Crushed plant is used in pneumonia.  
 Infusion of the root is used as mild astringent in bowel complaints. 
 Decoction of powder leaves with honey or sugar candy is useful in early stages of 
diarrhoea and dysentery. 
 The plant is used in the treatment  of asthma, bleeding piles, boils, bronchitis, cold, 
cough, colic, dropsy, ear complications, headache, leucoderma, pneumonia, renal 
complications, skin diseases, snake bite and  scorpion bite.
(8)
 
 The flowering spikes or seeds, ground and made into a paste with water, are used as 
external application for bites of poisonous snakes and reptiles, used in night blindness 
and cutaneous diseases  
 For snake bites the ground root is given with water until the patient vomits and 
regains consciousness. 
 Inhaling the fume of Achyranthes aspera mixed with Smilax ovalifolia roots is 
suggested to improve appetite and to cure various types of gastric disorders.
[12].
 
 Ash of the plant is applied externally for ulcers and warts. 
 The crushed leaves rubbed on aching back to cure strained back.[13]. 
 Paste of the roots in water is used in ophthalmia and opacities of the cornea. 
 Paste of fresh leaves is used for allaying pain from bite of wasps.(14) 
 The plant is useful in liver complaints, rheumatism, scabies and other skin diseases. It 
also possesses tranquillizing properties. 
[15, 16]
 
Scientific Review: 
Achyrathes aspera:  Diuretic Activity and Acute toxicity study
(17) 
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Muhammad Asif et.al.  Studied that the acute toxicity, diuretic activity and saluretic 
activity of Achyranthes aspera Linn Crude Aqueous Extract in Albino mice and Albino Rats 
respectively.The findings of this study demonstrated that the crude aqueous extract of the 
plant showed significant diuretic (p < 0.001), natriuretic (p < 0.001) and kaliuretic (p < 0.001) 
effects. Lipschitz values showed that, at the dose of 50 mg/kg, the crude extract showed 46 % 
of diuretic activity as compared with furosemide. No toxic effects were observed among 
Albino mice even at a higher dose of 3000 mg/kg. The conclusion of this study, the crude 
extract of Achyranthes aspera increases the urine volume and concentration of urinary 
electrolytes in a dose-dependent manner. Therefore, this plant has a diuretic potential. 
Diuretic Activity:
(18)
 
  S.S. Gupta et al. (1972) reported a saponin isolated from the seeds of Achyranthes 
aspera which shows significant diuretic effect in adult male albino rats. Achyranthine (5 
mg/kg, orally) had diuretic activity in rats. 
Sub-acute toxicity:
(19) 
 
The sub-acute toxicity studies of Methanolic extract of Achyranthus aspera revealed 
that the mice did not show any external manifestation of toxic symptoms, other behavioural 
patterns and mortality even after 30 days of drug administration (25mg/kg/day and 
50mg/kg/day). It did not produce any statistically significant changes in the body weights 
food and water intake, haematological,bone marrow studies of differential leucocytes count 
and chromosomal morphology. But the present study also revealed that the significant 
changes were found in biochemical, histopathological and weight of the few major organs. 
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Musa paradisiaca
 
Common names: 
 Banana 
 Plantain  
Synonyms: 
 Musasapientum L.  
Vernacular names: 
Tamil  : Vaazhai 
Sanskrit : Kadali 
Telugu  : Atral, Kadali 
Malayalam : Vazha 
Taxonomical classification:
(16) 
Kingdom : Plantae – Plants  
Division : Magnoliophyta 
Class   : Liliopsida 
Subclass : Zingiberidae 
Order  : Zingiberales 
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Family  : Musaceae 
Genus  : Musa  
Species : paradisiaca L 
Parts used: 
Roots, leaves, fruits and stem.  
Phytochemical constituents:
( 11)
 
 Nor-epinephrine 
 Indole compounds 
 Flavonoids 
 Vitamin-B 
 Vitamin-C 
 Albuminoids 
 Mineral salts 
 Tanins 
 Eugenol 
 
Actions: 
 Acrid 
 Anthelmintic 
 Tonic 
 Appetizer 
 
Medicinal Uses: 
(11)
 
 
 It is useful in kapha disease, pain in the ear, menstrual disorders, diseases of 
the blood, acid dyspepsia and leprosy. 
 The juice of the tender root is used with mucilage for checking hemorrhage from 
the genital and air passages. Mixed with ghee and sugar it is given for gonorrhoea 
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 The juice of the stem is cooling, astringent in action, anti-dysenteric, useful in thirst, 
Urinary discharges and leprosy. 
 Unripe fruit in combination with other drug is used in diabetes. 
 The ripe fruit is sweet, acrid, cooling, tonic, aphrodisiac, excites appetite, useful in 
Leprosy, thirst, vaginal and urinary discharges 
     
     
Borassus Flabellifer Linn.
 
Common name: 
 Palmyra palm 
Synonyms:  
 Borassus flabeliformis L 
 Borassus tunicatusLour 
 BorassusflabeliformisRoxb 
Vernacular names: 
Sanskrit : Tala 
Hind    : Taltar 
Telugu   : Tatichettu 
Toxonomicalclassification:
(16)
 
Kingdom  : Plantae 
Subkingdom  : Tracheobionata 
Division  : Magnoliophyta 
Class  : Liliopsida 
Order  : Arecales 
Family  : Arecaceae 
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Genus  : Borassus 
Species : flabellifer 
Parts used: 
 Root, flowering stalk, juice, bark and fruits. 
 
Phytochemical constituents: 
 Gum 
 Fat 
 Albuminoids (11) 
Actions: 
Root      : Cooling and restorative. 
Juice      : Diuretic, cooling and stimulant. 
Pulp from unripe fruit : Diuretic, demulcent and nutritive. 
Terminal buds   : Nutritive and diuretic. 
Medicinal Uses:
(11) 
 It cures vayu gunmam, burning micturition, dental disease and fever. 
 Ashes of flowering stalks are diuretics.Salt prepared from ashes of flowering stalk 
diluted with water then filter it pure ashless diluted water exposure to sunlight. It 
contains albuminoids, gum and fat. 
 Juice is diuretics, cooling andstimulant. It is used for dropsy and inflammation.  
 Ashes of flowering stalk are useful in enlarged spleen. 
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Solanum Melogena, Linn. 
Common names: 
 Brinjal 
 Egg plant 
Vernacular names: 
Sanskrit :  Vartaku, Bartaku, Peethaphala 
Telugu  :  Vankayi 
Hindi  : Begun 
Toxonomical classification:
(16) 
Kingdom     :  Plantae  
Division      :  Magnoliophyta 
Class           :  Magnoliopsida 
Order          :  Solanales 
Family       :  Solanaceae 
Genus         :  Solanum 
Species    :   melongena 
Parts used: 
 Whole plant 
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Phytochemical constituents:
(8)
 
Green leaves    :    Antiscorbutic vitamin C 
Dried material  :Ether extract  
   Albuminoids  
Nitragen  
Actions: 
Leaves  : Narcotic 
Seeds   : Stimulant 
Fruits   : Hypnotic, Phlegmatic. 
Tender fruits : Antiphlegmatic, Alleviative of wind. 
Riped fruits : Carbonas, Bilious. 
Burnt fruits : Light in digestion, Purgative, Beneficial in 
obesity and phlegm. 
Medicinal Uses:
 (11)
 
 Fruit is generally used as culinary vegetable, made into pickles. 
 Pierced all over with a needle and fried in gingelly oil the fruit is employed as a cure 
for toothache. 
 It is an excellent remedy for liver diseases. 
 Seeds are apt to lead to dyspepsia and constipation. 
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Uncaria Gambir .Roxb, 
Common name: 
 Pale catechu  
Synonym: 
 Naucleagambir 
Vernacular names: 
 Tamil   : Ankudu- kurra 
 Sanskrit  : Khadir 
 Hindi   : Kath 
 Marathi   : Kath 
 Malayalam : Gambier, Gambir. 
Botanical classification:
(16) 
 Kingdom   : Plantae 
 Division   : Angiospermae 
 Class   : Eudicots 
 Order   : Gentiales 
 Family  : Rubiacea 
 Genus   : Uncaria 
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 Species  : Gambir 
Parts used: 
  Extract 
 
 
Phytochemical constituents:
(11) 
 Catechu-Tannic Acid  
 Catechine  
 Quercetin,  
 Catechu-Red 
 Gambir - Fluorescein 
 Wax 
 Oil  
Action: 
 Local astringent 
Medicinal Uses:
(11) 
 It is largely used as an ingredient in pan – supari (Betel leaf). 
 Externally it is an application to syphilitic sores and ulcers in mouth. 
 The official tincture diluted with water can be used as a gargle in sore throat, 
stomatitis. 
 Internally, in combination with chalk, kino and opium. It is a useful preparation in 
diarrhoea and cholera. 
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3.3. MINERALOGICAL ASPECT 
BORAX 
Occurrence: 
It occurs as a natural deposit. Crude borax is found in masses by evaporation of water, 
on shores of dried up lakes in India and Tibet. It is also obtained from the mud of lakes 
surrounded by hills in Nepal. 
Synonyms: 
 SodiiBoras 
 SodiiBiboras 
 Sodium Borate 
General Characters: 
It is composed of boric acid and soda. 
The color is greyish white.On exposure it becomes opaque or dirty white. 
It has a faintly balsamic odour. 
Physical Characters: 
Appearance    : White solid 
Melting point   : 741
0
c 
Boiling point    : 1575
0
c 
Molar mass   : 381.37 
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Density       : 1.73 gm 
Related compounds  : Boric acid, Sodium per borate 
Molecular formula   : Na2 B4 O7 10H2O 
 
 
Actions: 
 Diuretic 
 Emmenogogue 
 Astringent 
 Antacid 
 Local sedative 
 Antiseptic 
Medicinal uses: 
(20) 
 It is given internally at the dose of10-30 grains, for acidity of the stomach, 
amenorrhea, dysmenorrhea, menorrhagia, puerperalconvulsions and to promote 
uterine pains during labor. 
 Roasted borax is given with tender coconut water for urinary tract infections. 
 It is given at a dose of 260-520 mg with betel leaf prevents fever with rigor. 
 65 mg to 325 mg of borax mixed with breast milk is given to children for relief of 
pain and convulsions. 
 325 mg of borax and 195 mg of pepper powder are taken together with 4 ml of honey 
thrice a day for controlling asthma and cough.  
 Vengaraparpam cures pitha diseases like burning micturition and urolithiasis. 
Supportive articles: 
 
1) The Vengaram is one of the ingredients of the drug Jalamanjari  chendooramin 
siddha system of medicine which is used for kidney stone diseases . It has significant 
diuretic activity. 
(21) 
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2)  The Vengaram is one of the ingredients of Kara Sooda Sathu Parpam is indicated for 
diuretic and lithontriptic activity in the management of urolithiasis. 
(22)
 
3) The Vengaram is one of the ingredients of the drugSarva noi Llinga Chendooram is 
indicated for diuretic and lithontriptic in the management of urolithiasis.
 (23)
 
 
 
 
ALUMEN 
Occurrence: 
Chiefly fond with peroxide of iron in Silajit or in Alum earths of Nepal or prepared 
from alum shale in the Punjab, Rajputana and Bihar States.Alum is a general name for a class 
of double sulphates containing aluminium and such metals as potassium, ammonium, iron 
etc. 
Synonyms:  
 Alum 
 Aluminium Potassium Sulphate 
General Characters: 
Colourless, transparent crystals. It is with acid and has sweetish astringent taste. 
Physical Properties: 
Melting point          :    660.37
0
c 
Boiling point           :    24670
0
c 
Specific gravity       :   2.6989200
0
c 
Molecular formula   :    KA1 (SO4)212H20 
Actions: 
 Astringent 
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 Hemostatic 
 Antispasmodic 
 Antiseptic 
 Irritant  
 Purgative in large doses 
 Emetic in repeated doses 
 
Medicinal uses:
(20) 
 It cures gingivitis, filariasis, heart diseases, vatham, fever, peptic ulcer, and tumour.  
 Padikaraparpam has been used for urinary calculus, urethral stricture, anuria and 
burning micturition. 
 It also controls vomiting when given at a dose of 65 mg. 
 4.7 gm of alum dissolved in butter milk is given for snake bites. 
 For severe head injury, 130 mg of alum is administered along with sugar. 
 In leucorrhoea with bleeding, alum is given with juice of Adathodavasaica thrice 
daily.
(17)
 
Supporting article: 
 The padigaram is one of the ingredients of KaraSooda Sathu Parpam is indicated for 
diuretic activity and lithontriptic activity in the management of urolithiasis. 
(22) 
 
 
 
 
 
 
 
 
 
 
33 
 
 
 
 
 
 
 
 
 
ROCK SALT 
Occurrence: 
 Found in nature in extensive beds mostly associated with clay and calcium sulphate. 
To obtain it, holes are dug into these rocks which soon become filled up with salt water. The 
water is evaporated and the salt is left ready for use. 
Halitecommonly known as rock salt. It is the mineral form of sodium chloride (NaCl). 
Halite forms isometric crystals. 
Synonym:  
 Sodium Chloride impurae 
Vernacular names: 
Tamil  : Indhuppu 
Eng  : Rock salt 
Hindi  : Sendhalon 
General Characters: 
It is found in small white crystalline grains or transparent cubes. It is brownish 
white externally and white internally. It has a pure saline taste and burns with a 
yellow flame. 
Physicochemical properties: 
Category  : Halide mineral 
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Chemical formula : NaCl 
Crystal symmetry : Isometricalhexoctahedral 
Molar mass  : 58.433g/mol 
Solubility  : Water soluble        
Crystal system : Cubic 
Luster   : Vitreous 
Optical properties : Isotropic 
Streak   : White 
Refractive index : 1.544 
Other characters : Salty flavor, Fluorescent 
Actions: 
 Carminative 
 Diuretic 
 Laxative 
 Purgative 
 Stomachic  
 Digestive 
Medicinal uses :
( 20)
 
 It promotes the appetite and assists digestion and assimilation. 
 Hot fomentation of the rock salt can be taken for curing the painful swellings. 
 It is made into a paste and applied in case of sprain. 
 It is given in dyspepsia and other abdominal disorders. 
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SODIUM CARBONATE 
Occurrences and Varieties: 
It occurs in porous, granular masses, of a greyish white color or as heavy hard pieces, 
with a strong alkaline taste of soda. 
3 varieties - 1.Sajjikhar, 2.Soda crystals, 3.Very impure carbonate of soda. 
All these varieties are found in the ashes of Chenopodiaceous plants, a species of salt 
worsts growing near the sea. 
Crude carbonate or sulphate of soda is an alkaline earth found in large quantities 
where white forms the sub-soil. 
It is found in the hot weather as an efflorescent sand.It is scrapped off from surface 
with a little quicklime and made into cubes for sale, in cart loads 
Synonyms:  
 SodiiCarbonasImpura 
 Disodium carbonate 
 Carbonic acid disodium salt 
 Calcined soda. 
Vernacular names: 
Tamil  : Choontumunnoo, Sanchhikkaram 
Sanskrit : Natron, Sarjikakshara 
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English  : Dhobi‟s earth, Salphate of soda 
Telugu  : Savitemannuppu 
Hindi   : Sajjikhar 
 
 
 
Constituents: 
It contains 25p.c. of Sodium carbonate. Chemically it consists of carbonate of soda 
with certain impurities such as organic matter, sulphate of soda, potash etc. 
Physical properties: 
Molecular weight : 105.988g/mol 
Color       : Greyish – white powder or lumps containing upto 99%  
    Sodium carbonate 
Melting point  : 856
0
c  
Solubility  : 30.7 gm/100g water at 25
0
c  
Molecular formula : NA2CO3 or NA2O3. 
Actions: 
 Antacid 
 Alterative 
 Diuretic 
Medicinal uses: 
(20)
 
 It is useful in dyspepsia, vomiting, diarrhoea and flatulence. 
 It is an efficient remedy in urinary diseases, gravel and suppression of urine. 
  In Bright‟ disease of the kidney with abundant sediment in the urine, and in 
diabetesthe habitual use of this salthas a marked beneficial effect. 
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4. MATERIALS AND METHODS 
The trial drug Kalladaippu Thool is a herbomineralpreparationindicated for 
urolithiasis has been chosen as a trial drug from the Siddha literature“Anuboga Vaithiya 
Navaneetham”,Vol-9,pgno:76,77., Author: Hakeem P.M.Abdullah sahib. 
Ingredients of Kalladaippu Thool: 
 1. Ash of Naayuruvi (Whole plant of Achyranthes aspera)  : 2 palam(70gm) 
2. Ash of Vaazhai charugu (Bark of Musa paradaisiaca)  : 2 palam(70 gm) 
3. Ash of Panai poo (Flower of Borassus flabelifer)   : 2 palam(70 gm) 
4. Ash of Katthari (Whole plant of Solanum melogena)  : 2 palam(70 gm) 
5. Powder of Katthakaambu (Stem of Uncaria gambir)  : 2 palam(70 gm) 
6. Purified Borax (Vengaram- Sodium Biborate)   : 2 palam(70 gm) 
7.  Purified Alum (Padigaram- Aluminium PottassiumSulphate) : 2 palam(70 gm) 
8.  Purified Rock Salt (Induppu- Sodium Chloride Impurae)  : 2 palam(70 gm) 
9.  Purified Sulphate of soda(Savukkaaram -Sodium Carbonate) : 2 palam(70 gm)            
Collection of the Plant materials: 
 All plant materials were freshly collected from in and around Trichy, Tamilnadu. 
Mineral drugs were procured from raw drug shop in Parrys, Chennai. 
Identification and Authentication of the drug: 
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All the plant materials were identified and authenticated by the Botanist, Department 
of Gunapadam, National Institute of Siddha.All the mineral materials were identified by the 
Chemist, Department of Geology, University of Madras, Guindy Campus, Chennai. 
Purification of the drugs: 
 All the drugs mentioned here were purified as per the Siddha literature. 
 The whole plant of Achyranthes aspera,Bark of Musa paradisiac,Flower of Borassus 
flabelifer and Whole plant of Solanum melogena was washed in the running tap water 
to remove the soil and impurities. 
 Extract of Uncaria gambir was cleaned well from  dust and impurities.(7) 
 Borax was fried till the moisture completely evaporates.(8) 
  Alumen was dissolved in water; filtered, boiled when it attained consistency of jelly. 
It was cooled to get the purified form.
(8) 
 Rock salt was soaked in goat‟s urine for three days and insolated to get purified 
form.
(8)
 
 Savukkaram was dissolved in water ,filtered, boiled and then cooled to get purified 
form.
(2)
 
Preparation of the Drug 
The whole plant of Achyrathes aspera barks of Musa paradaisiaca, flowers of 
Borasses flabelifer and whole plant of Solanum melongena were dried in the shade until 
complete evaporation of the moisture content.Then these were burnt to get ash. Extract of 
Uncaria gambir was dried in the shade and then powdered by using pulverize.                                                                     
The purified Vengaram, Padigaram, Induppu,Savukkaram were powdered by using stone 
mortar. Then filtered and mixed all of the ingredients andkept in an air tight container. It was 
labeled as Kalladaippu Thool. 
Date of preparation    : 9/8/16 and 14/8/16 
Dose    : 4gm 
Adjuvant     : Tender coconut water 
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Indication     : Kalladaippu (urolithiasis), Neeradaippu 
(dysuria)Sathaiyadaippu(urethral stricture), Moothirakiricharam(burning 
micturition),Thurmamisavalarchi(tumor inrenal tract). 
Date of expiry    : 1 year. 
 
Ingredients of Kalladaippu Thool 
Sodium chloride impurae 
Before purification    After purification 
    
Borax 
Before purificationAfter purification 
 
     Alum 
Before purification                 After purification 
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Sodium carbonate 
Before purification                                After purification 
 
 
 Naayuruvi   - (Achyranthes aspera)          Katthari - (Solanum melongena)                                      
 
 
Katthakaambu- (Uncaria gambir)     Panai poo - (Borassus flabellifer) 
41 
 
 
 
 
 
Vaazhai charugu - (Musa paradisiaca) 
 
 
 
 
 
 
 
KALLADAIPPU THOOL 
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4.1. ANALITICAL STUDIES OF KALLADAIPPU THOOL 
 
Analytical studyof the prepared drug brings the validation to be used as a medicine by 
subjecting the drug to many analysis and determining its quality and effectiveness. 
Standardization includes many studies such as its organoleptic properties, physicochemical 
properties and to assess the active principles and elements present in the drug. Thus analytical 
study brings the efficacy and potency of the drug. 
 
As per AYUSH protocol for analytical study, the following parameters were 
evaluated. 
 Organoleptic characters: 
 
 Colour 
 Odour 
 Taste  
 Texture 
 
 Physicochemical analysis: 
 
 Determination of Ash Values 
 Physical characterization 
 
 Phytochemical analysis: 
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 HPTLC and TLC finger print analysis 
 
 Chemical analysis: 
 
 Preliminary Basic and Acidic radical studies 
 
 Elemental analysis: 
 X-ray Powder Diffraction Analysis 
 
 
 
 
4.1.1 ORGANOLEPTIC CHARACTERIZATION OF KALLADAIPPU THOOL 
The organoleptic characters of the sample drug were evaluated. 1gm of the test drug 
was taken and the following characters were seen. 
Colour, Odour, Taste, Texture and other morphology were viewed by naked eye 
under sunlight. Then the result was noted. 
Colour: 
The medicine was taken into watch glasses and placed against white back ground in 
white tube light. It was observed for its colour by naked eye. 
Odour: 
The medicine was smelled individually. The time interval among two smelling was 
kept 2 minutes to nullify the effect of previous smelling. 
Results: 
The results of organoleptic character were showed in Table – 1 
4.1.2. PHYSICO CHEMICAL ANALYSIS: 
Determination of Ash Values: 
Total Ash: 
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3gm is accurately weighed and incinerated in a crucible dish at a temperature not 
exceed 450
o
C until free from carbon. It was then cooled and weighed. The % w/w of ash with 
reference to the air-dried powder was calculated. 
Water Soluble Ash: 
The total ash was obtained as the above method for preparation of total ash. The ash 
was boiled for 5minutes with 25ml water. The insoluble ashes was collected using filter paper 
and washed with hot water and then transferred to the silica crucible then ignite for 
15minutes at temperature not exceeding 450
o
C. The silica crucible and residue were weighed 
until constant weight was attained for determination of weight of insoluble ash. The weight of 
the water soluble ash was determined by subtracting the weight of insoluble ash from the 
weight of total ash. 
Acid insoluble Ash: 
The total ash was obtained as the above method for preparation of total ash. The ash 
was boiled for 5minutes with 25ml 10% HCl. The insoluble ashes is collected using filter 
paper and washed with hot water and then transferred to the silica crucible then ignite for 
15minutes at temperature not exceeding 450
o
C. The silica crucible and residue were weighed 
until constant weight is attained. 
Loss on Drying: 
The powdered drug is dried in the oven at 100- 105°C to constant weight.  
Determination of Alcohol Soluble Extractive: 
The air dried drug was finely grounded, added with 100 ml of ethanol of specified 
strength in a closed flask for twenty-four hours, shaken frequently during the course of six 
hours and allowed to stand for eighteen hours. Then the mixture was filtered rapidly taking 
precautions against loss of solvent, 25 ml of the filtrate was evaporated to dryness in a tarred 
flat bottomed shallow dish, and dried at 105º to constant weight. The percentage of alcohol-
soluble extractive with reference to the air-dried drug was estimated. 
Determination of Water Soluble Extractive: 
The above procedure was repeated but instead of ethanol, chloroform with water was 
used. 
Results: 
The results of physicochemical properties were represented in Table - 2. 
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4.1.3 CHEMICAL ANALYSIS OF KALLADAIPPU THOOL 
The chemical analysis of Kalladaippu thool was carried out in bio chemistry lab, National 
Institute of Siddha. 
S.No EXPERIMENT OBSERVATION INFERENCE 
1.  Physical Appearance of extract Dark brown in 
colour. 
 
2. Test for Slicate : 
500mg of the sample was shaken well 
with distilled water. 
 
Sparingly soluble. 
 
 
Presence of Silicate. 
 
 
3. Action of Heat: 
500mg of the sample was taken in a 
dry test tube and heated gently at first 
and then strong. 
 No White fumes 
evolved. 
No brown fumes 
evolved. 
 
Absence of 
Carbonate 
Absence of Nitrate. 
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4. Flame Test: 
500mg of the sample was made into a 
paste with con. HCl in a watch glass 
and introduced into non-luminous part 
of the Bunsen flame. 
 
 
No bluish green 
flame appeared. 
 
 
Absence  of copper 
 
 
 5. Ash Test: 
A filter paper was soaked into a 
mixture of extract and dil. cobalt 
nitrate solution and introduced into the 
Bunsen flame and ignited. 
 
Appearance of yellow 
colour flame 
appeared. 
 
 
 
 
 
flame  
 
 
 
flame 
 
Absence of sodium 
 
 
Preparation of Extract 
 5gm of sample was taken in a 250ml clean beaker and added with 50ml of distilled 
water. Then it is boiled well for about 10 minutes. Then it is cooled and filtered in a 100ml 
volumetric flask and made up to 100ml with distilled water. This preparation is used for the 
qualitative analysis of acidic/basic radicals and biochemical constituents in it. 
S.No EXPERIMENT OBSERVATION INFERENCE 
 I. Test For Acid Radicals   
1. Test For Sulphate: 
2ml of the above prepared extract 
was taken in a test tube to this added 
2ml of 4% dil ammonium oxalate 
solution 
Cloudy appearance 
present. 
Presence of 
Sulphate. 
2. Test For Chloride: 
2ml of the above prepared extracts 
was added with 2ml of dil-HCl until 
the effervescence ceases off. 
No Cloudy appearance 
present. 
 
Absence of 
Chloride. 
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3. Test For Phosphate: 
2ml of the extract were treated with 
2ml of 
dil.ammoniummolybdatesolution. 
No Cloudy yellow 
appearance present. 
Absence of 
Phosphate  
4.  Test For Carbonate: 
2ml of the extract was treated with 
2ml dil. magnesium sulphate 
solution. 
 
No cloudy appearance 
present. 
 
Absence of  
carbonate 
 
5 Test For Nitrate: 
1gm of the extract was heated with 
copper turning and concentrated 
H2So4 and viewed the test tube 
vertically down. 
 No Brown gas was 
evolved. 
 
Absence of 
nitrate. 
6. Test For Sulphide: 
1gm of the extract was treated with 
2ml of con. HCL 
 No rotten egg smelling 
gas was evolved. 
Absence of 
sulphide. 
 
7. 
Test For Fluoride & Oxalate: 
2ml of extract was added with 2ml of 
dil. Acetic acid and 2ml dil.calcium 
chloride solution and heated. 
 No cloudy appearance. 
Absence of 
fluoride and 
oxalate 
8. Test For Nitrite: 
3drops of the extract was placed on a 
filter paper, on that-2 drops of 
dil.acetic acid and 2 drops of 
dil.Benzidine solution is placed. 
No characteristic 
changes. 
Absence of nitrite 
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9. Test For Borate: 
2 Pinches (50mg) of the extract was 
made into paste by using 
dil.sulphuric acid and alcohol (95%) 
and introduced into the blue flame. 
Bluish green colour 
flame not appeared. 
Absence of 
borate. 
II. Test For Basic Radicals 
1. Test For Lead: 
2ml of the extract was added with 2ml 
of dil.potassium iodine solution. 
No Yellow colour 
precipitate was 
obtained. 
Absence of lead. 
2. Test For Copper: 
One pinch (25mg) of extract was made 
into paste with con. HClin a watch glass 
and introduced into the non-luminuous 
part of the flame. 
No blue color 
precipitate appeared. 
  Absence of    
copper. 
3. Test For Aluminium: 
To the 2ml of extract dil.sodium 
hydroxide was added. 
No characteristic 
changes. 
 
 
 
 
 
 
 
 
 
characteristic changes 
chara 
Absence of    
Aluminium. 
 
 
 
 
 
 
 
 
 
 
 
 
4. Test For Iron: 
a. To the 2ml of extract add 2ml of 
dil.ammonium solution 
b. To the 2ml of extract 2ml  
thiocyanate solution and 2ml  of con 
HNo3 was added. 
 Red color appeared. Presence of Iron. 
5. Test For Zinc:  
To 2ml of the extract dil.sodium 
hydroxide solution was added in 5 drops 
to excess and dil.ammoniumchloride 
was added.  
No White precipitate 
was formed. 
Absence of Zinc. 
49 
 
6. Test For Calcium:  
2ml of the extract was added with 2ml 
of 4% dil.ammonium oxalate solution. 
Presence Cloudy 
appearance and white 
precipitate was formed. 
Presence of 
calcium. 
7. Test For Magnesium:  
To 2ml of extract dil.sodium hydroxide 
solution was added. 
No White precipitate 
was obtained. 
Absence of 
magnesium. 
8. Test For Ammonium: 
To 2ml of extract 1 ml of Nessler's 
reagent and excess of dil.sodium 
hydroxide solution were added. 
 No Brown color 
appeared. 
Absence of 
ammonium. 
9. Test For Potassium: 
A pinch (25mg) of extract was treated 
with 2ml of dil.sodium nitrite solution 
and then treated with 2ml of dil.cobalt 
nitrate in 30% dil.glacial acetic acid. 
  No Yellow precipitate 
was obtained. 
Absence of 
potassium. 
10. Test For Sodium: 
2 pinches (50mg) of the extract was 
made into paste by using HCl and 
introduced into the blue flame of 
Bunsen burner. 
No yellow color flame 
evolved. 
 
 
 
 
 
 
 
 
 
 
 
 
Absence of 
sodium. 
11. Test For Mercury:  
2ml of the extract was treated with 2ml 
of dil.sodium hydroxide solution.  
 No Yellow precipitate 
is obtained. 
 
Absence of 
Mercury. 
 
 
12. Test For Arsenic:  
2ml of the extract was treated with 2ml 
of dil.sodium hydroxide solution. 
No  Brownish red 
precipitate was 
obtained. 
Absence of 
arsenic. 
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III Miscellaneous 
1.
  
Test For Starch: 
2ml of extract was treated with weak 
dil.Iodine solution. 
 
 
 
 
 
 
  No Blue color 
developed. 
Absence of starch. 
2.
  
Test For Reducing Sugar: 5ml of 
Benedict's qualitative solution was 
taken in a test tube and allowed to boil 
for 2 minutes and added 8 to 10 drops 
of the extract and again boil it for 2 
minutes.  
 
 
 
 
 
 
 
noted. 
 No Brick red color was 
developed. 
 
Absence of 
reducing sugar. 
 
 
3. Test For The Alkaloids: 
a) 2ml of the extract was treated with 
2ml of dil.potassiumlodide solution. 
b)  2ml of the extract was treated with 
2ml of dil.picric acid. 
c)  2ml of the extract was treated with 
2ml of dil.phosphotungstic acid. 
 
 
No Yellow color 
developed. 
 
 
Absenceof 
Alkaloid. 
4.
  
Test For Tannic Acid:  
2ml of extract was treated with 2ml of 
dil.ferric chloride solution  
 Blue-black precipitate 
was obtained. 
Presence of 
Tannic acid. 
5.
  
Test For Unsaturated Compound: 
To the 2ml of extract 2ml of 
dil.Potassium permanganate solution 
was added.  
 Potassium 
permanganate was not 
decolorized. 
 
Absence of 
unsaturated 
compound. 
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Results: 
The results of acid and basic radicals were showed in Table: 3 - 4. 
4.1.4 TLC/HPTLC FINGER PRINT ANALYSIS 
Thin layer chromatography (TLC) is a chromatographic technique used to separate 
the components of a mixture using a thin stationary phase supported by an inert backing. It 
6.
  
Test For Amino Acid: 
2 drops of the extract was placed on a 
filter paper and dried well. 20ml of 
Burette reagent was added. 
 
 
No violet color 
appeared. 
Absence of amino 
acid. 
7. Test For Type of Compound: 
2ml of the extract was treated with 2 ml 
of dil.ferric chloride solution.  
No green and red color 
developed. 
 
 
 
 
No Violet color 
developed 
 
 
sNo Blue color 
developed. 
 
Absence of 
quinolepinephrine
pyrocatechoantipy
rine, Aliphatic 
amino acid and 
meconicacid.  
 
Apomorphine 
salicylate and 
Resorcinol are 
absent  
Morphine, Phenol 
cresol and 
hydrouinone are 
present. 
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may be performed on the analytical scale as a means of monitoring the progress of a reaction, 
or on the preparative scale to purify small amounts of a compound. 
TLC/HPTLC is an analytical tool widely used because of its simplicity, relative low 
cost, high sensitivity, and speed of separation. TLC/HPTLC functions on the same principle 
as all chromatography: a compound will have different affinities for the mobile and stationary 
phases, and this affects the speed at which it migrates. The goal of TLC/HPTLC is to obtain 
well defined and well separated spots. 
TLC and HPTLC Methodology 
 4g of fine powdered extracted with 40ml of  Ethanol soaked for 24 hours. The 
extract was filtered, concentrated and made up to 10 ml in a standard flask. 5µl, 10µl, 15µl of 
the solution were applied on Merck Aluminium plate pre-coated with Silica gel 60 F 254 of 
0.2 mm thickness to a band width of 6 mm using Canag HPTLC system equipped with ATS- 
Iv applicator. The plate was developed in Toluene: Ethyl acetate: Formic acid(4:6:0.1). The 
plate was dried and visualized in UV 254 and UV 366 nm and photographs were taken. 
Before derivitization of the plate it was scanned at UV 254 nm and Fingerprint was taken 
before dipping in Vanillin- Sulphuric acid reagent 
Retention Factor: 
After a separation was complete, individual compounds appear as spots separated 
vertically. Each spot has a retention factor (Rf) which is equal to the distance migrated over 
the total distance covered by the solvent. The Rf formula is 
Rf = distance traveled by sample /distance traveled by solvent: 
The Rf value can be used to identify compounds due to their uniqueness to each 
compound.  When comparing two different compounds under the same conditions. 
The compound with the larger Rf value is less polar because it does not stick to the 
stationary phase as long as the polar compound, which would have a lower Rf value. 
Results: 
The results of Rf were represented in Table - 5. 
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4.1.5 DETERMINATION OF HEAVY METALS ANALYSIS 
The procedure recommended for analysis of Heavy metals as per the guidelines WHO 
(1998) and AOAC (2005).    
Instrument details:  
 Thermo FisherM Series, 650902 V1.27 model Atomic Absorption Spectrometer (AAS) 
was used for the analysis. The operating parameters:  
Lead and Cadmium:  
Instrument technique  : sFlame technique 
Wavelength (Lead)  : 217 nm 
Wavelength (Cadmium) : 228.8 nm 
Slit width    :  0. 5 mm 
Lamp current (Pb)   :  4.0 mA 
Lamp current (Cd)   :  3.0 mA  
Carrier gas and flow rate : Air and Acetylene, 1.1 L/min 
Flow rate   : 2 ml/min 
Mercury:  
Instrument technique  : Cold vapour technique 
Wavelength    : 253.7 nm 
Slit width    : 0. 5 mm 
 Lamp current    : 3.0 mA,  
Carrier gas and flow rate : Argon, 1.1 L/min 
Flow rate   : 5ml/min 
Arsenic:  
Instrument technique : Flame vapour technique 
Wavelength    : 193.7nm 
Slit width    : 0. 5 mm 
 Lamp current    : 6.0 mA,  
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Carrier gas and flow rate : Acetylene, Argon, 1.1 L/min 
Flow rate   : 5ml/min 
The Hallow cathode lamp for Pb, Cd, Hg and As analysis were used as light source to 
provide specific wavelength for the elements to be determined. 
Results: 
The results of heavy metals analysis were represented in Table -6. 
 
 
 
 
 
4.1.6 DETERMINATION OF MICROBIAL LOAD AND AFLOTOXINS 
Test for Microbial load:  
The procedures recommended for analysis of microbial load as per the guideline 
(WHO, 2007). 
The test included total bacterial count, total fungal count, and identification of specified 
organisms such as Enterobacteriaceae, Escherichia coli, Salmonella spp and Staphylococcus 
aureus. 
Test for Aflatoxins:  
The procedures recommended for the detection of Aflatoxin as per WHO (2007).   
Instrument Details 
Name of the Instrument : CAMAG (CAMAG - Automatic TLC sampler, 
   Scanner and Visualiser) 
Spray Gas : N2 
Lamp used : Deuterium and Tungsten Lamp 
Results: 
The results of microbial load and aflotoxins were represented in Table -7. 
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4.1.7 X-RAY POWDER DIFFRACTION (XRD) 
The powder method of diffraction was devised independently by Debye and Scherrer. 
Powder diffraction method involves the diffraction of monochromatic X-rays by a powder 
specimen. Monochromatic usually means a strong Kα characteristic component of the filtered 
radiation from an X-ray tube operated above the Kα excitation potential of the target material. 
 Selection of Kα renders the incident beam to be a highly monochromatised one. The 
focusing monochromatic geometry results in narrower diffracted peaks and low background 
at low angles. The sample is mounted vertically to the seemann- Bohlin focusing circle with 
the scintillation counter tube moving along the circumference of it. It is possible to record the 
diffracted beam from 2 to160 degrees. The diffract meter is connected to a computer for data 
collection and analysis. The scintillation counter tube can be moved in step of 0.01 degree by 
means of a stepper motor and any diffracted beam can be closely scanned to study the peak 
profile. 
Identification of the material: 
 The powder diffraction of a substance is characteristic of the substance and forms a 
short of fingerprint of the substance to be identified. The peak of the X-ray diffraction pattern 
can be compared with the standard available data for the conformation of the structure. For 
the purpose of comparison, many standards are available, some of which are, Willars hand 
book, Joint Committee on Powder Diffraction Standards (JCPDS) Pepdfwin and National 
Bureau of Standards. 
Results: 
In XRD Study the sample of Kalladaippu Thool is matched with standard graph of 
Natroxlate, Sodium chloride, Sodium boron, Potassium carbonate, potassium sulphide and 
Boron carbide. So the drug taken for my study indicates the presence of Natroxlate, Sodium 
chloride, Sodium boron, Potassium carbonate, potassium sulphide and Boron carbide. 
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5. TOXICOLOGICAL EVALUATION OF KALLADAIPPU THOOL 
Introduction: 
Safety is a fundamental principle in the provision of traditional medicines and herbal 
products for health care and a critical component of quality control. OECD guidelines 
provide practical and technical guidance for monitoring the safety of traditional medicines 
within pharmacovigilance systems. The safety monitoring of traditional medicines is 
compared and contrasted with that of other medicines, currently undertaken in the context of 
the WHO International Drug perspective. 
Scope of work: 
Monitoring programme. While there are regulatory and cultural differences in the 
preparation and use of different types of medicines, they are all equally important from a 
pharmacovigilance. 
Assurance of safety, quality and efficacy of Indian System of Medicines (ISM) is the 
key issue that needs to be addressed while conducting toxicity studies. It is an essential step, 
which will strengthen the acceptance of Siddha medicines by scientific community. 
Information of toxicity and adverse effects of these formulations are lacking. Some of the 
formulations are proved to be effective in various animal studies and many more are yet to be 
tested.  
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Hence, the present study was carried out to evaluate the Preclinical toxicity studies 
ofKalladaippu Thool in rodents. 
Plan of work: 
The following studies were carried out on Kalladaippu Thool 
 Acute Oral toxicity – OECD 423 
 28-Days Repeated  Oral Toxicity Study – OECD 407 
 90 days chronic toxicity study-OECD 408 
 
 
 
 
 
 
 
5.1 ACUTE ORAL TOXICITY STUDY OF KALLADAIPPU THOOL 
(OECD GUIDELINE – 423) 
Introduction: 
 The acute toxic class method is a stepwise procedure with the use of 3 animals of 
a single sex per step. 
 Depending on the mortality and/or the moribund status of the animals, on average 
2-4 steps may be necessary to allow judgment on the acute toxicity of the test 
substance.  
 This procedure is reproducible, uses very few animals and is able to rank 
substances in a similar manner to the other acute toxicity testing methods.  
 The acute toxic class methodis based on biometric evaluations with fixed doses, 
adequately separated to enable a substance to be ranked for classification purposes 
and hazard assessment.  
 In principle, the method is not intended to allow the calculation of a precise LD50, 
but does allow for the determination of defined exposure ranges where lethality is 
expected since death of a proportion of the animals is still the major endpoint of 
this test.  
 The method allows for the determination of an LD50 value only when at least two 
doses result in mortality higher than 0% and lower than 100%.  
58 
 
 The use of a selection of pre-defined doses, regardless oftest substance, with 
classification explicitly tied to number of animals observedin different states 
improves the opportunity for laboratory to laboratory reporting consistency and 
repeatability.  
Principle of the Test:  
It is the principle of the test that based on a stepwise procedure with the use of a 
minimum number of animals per step; sufficient information is obtained on the acute toxicity 
of the test substance to enable its classification. The substance is administered orally to a 
group of experimental animals at one of the defined doses. The substance is tested using a 
stepwise procedure, each step using three animals of a single sex. Absence or presence of 
compound-related mortality of the animals dosed at one step will determine the next step, i.e. 
− No further testing is needed 
− dosing of three additional animals, with the same dose  
− dosing of three additional animals at the next higher or the next lower dose level.  
The method will enable a judgment with respect to classifying the test substance to 
one of a series of toxicity classes. 
Methodology: 
Selection of Animal Species: 
 The preferredrodent speciesis the wistar albino rat, although other rodent species may 
be used. Healthy young adult animals are commonly used laboratory strains should be 
employed. Females should be nulliparous and non-pregnant. Each animal, at the 
commencement of its dosing, should be between 6 to 8 weeks old and the weight (150-
200gm) should fall in an interval within±20 % of the mean weight of any previously dosed 
animals.  
Housing and Feeding Conditions: 
The temperature in the experimental animal room should be 22ºC + 3ºC.  Although 
the relative humidity should be at least 30% and preferably not exceed 70% other than during 
room cleaning the aim should be 50-60%. Lighting should be artificial, the sequence being 12 
hours light, 12 hours dark. For feeding, conventionallaboratory diets may be used with an 
unlimited supply of drinking water. Animals may be group-cagedby dose, but the number of 
animals per cage must not interfere with clear observations of each animal. 
Selection of animals: 
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The animals are randomly selected, marked to permit individual identification, and 
kept in their cages for at least 7 days prior to do sink to allow for acclimatization to the 
laboratory conditions. 
Test Animals and Test Conditions: 
 Sexually mature Female Wistar albino rats (150-200gm) were obtained 
fromTANUVAS, Madhavaram, Chennai.All the animals were kept under standard 
environmental condition (22±3°C).  The animals had free access to water and standard pellet 
diet (Sai meera foods, Bangalore). 
Preparation for Acute Toxicity Studies: 
 Rats were deprived of food overnight (but not water 16-18 h) prior to administration 
of theKalladaippu thool. The principles of laboratory animal care were followed and the 
Institutional Animal Ethical Committee approved the use of the animals and the study design 
(IAEC NO: IAEC/XLIX/18/CLBMCP/2016). 
 
Test Substance  : Kalladaippu Thool 
Animal Source  : TANUVAS, Madhavaram, Chennai.   
Animals   : Wister Albino Rats (Female-3+3) 
Age     :6-8 weeks 
Body Weight on Day 0 :150-200gm. 
Acclimatization  :Seven days prior to dosing. 
Veterinary examination :Prior and at the end of the acclimatization period. 
Identification of animals :By cage number, animal number and individual 
      marking by using Picric acid. 
Numberofanimals  : 3 Female/group,  
Routeofadministrate : Oral  
 
Diet     :Pellet feed supplied by Sai meera foods Pvt  
Ltd,Bangalore 
Water    :Aqua guard portable water in polypropylene bottles. 
Housing & Environment :The animals were housed in Polypropylene cages  
    provided with bedding of husk. 
Housing temperature :between 22ºC +3ºC.  
Relative humidity  :between 30% and 70%, 
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Air changes    :10 to 15 per hour  
Dark and light cycle   :12:12 hours. 
Duration of the study :14 Days 
Administration of Doses:  
 Kalladaippu Thool was suspendedin coconut water and administered to the groups of 
wistar albino rats in a single oral dose by gavage using a feeding needle. The control group 
received an equal volume of the vehicle. Animals were fasted 12 hours prior to dosing. 
Following the period of fasting, the animals were weighed and then the test substance was 
administered. Three Female animals are used for each group. The dose level of5, 50, 300and 
2000 mg/kg body weight was administered stepwise. After the substance has been 
administered, food was withheld for a further 3-4 hours. The principle of laboratory animal 
care was followed. Observations were made and recorded systematically andcontinuously as 
per the guideline after substance administration. The visual observations included skin 
changes, mobility, aggressively, sensitivity to sound andpain, as well as respiratory 
movements.Finally, the number of survivors was notedafter24 h and these animals were then 
monitored for a further 14 days and observations made daily. The toxicological effect was 
assessed on the basis of mortality. 
Observations:  
Animals are observed individually after dosing at least once during the first 30 
minutes, periodically during the first 24 hours, with special attention given during the first 4 
hours, and daily thereafter, for a total of 14 days, except where they need to be removed from 
the study and humanely killed for animal welfare reasons or are found dead. It should be 
determined by the toxic reactions, time of onset and length of recovery period, and may thus 
be extended when considered necessary. The times at which signs of toxicity appear and 
disappear are important, especially if there is a tendency for toxic signs to be delayed. All 
observations are systematically recorded with individual records being maintained for each 
animal. 
Observations include changes in skin and fur, eyes and mucous membranes and also 
respiratory, circulatory, autonomic and central nervous systems, somatomotor activity and 
behavior pattern. Attention was directed to observations of tremors, convulsions, salivation, 
diarrhea, lethargy, sleep and coma. The principles and criteria summarized in the Humane 
Endpoints Guidance Document taken into consideration. Animals found in a moribund 
condition and animals showing severe pain or enduring signs of severe distress was humanly 
killed. When animals are killed for humanreasons or found dead, the time of death was 
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recorded. 
Behaviour: 
 The animals will be observed closely for behaviour in the first four hours which  
includes abnormal gait, aggressiveness, exophthalmos, ptosis, akinesia, catalepsy, 
convolusion, excitation, head twitches, lacrimation, loss of corneal reflex, loss of traction, 
piloerection  reactivity of touch, salivation, scratching, sedation, chewing,  head movements, 
sniffing, straub, tremor and writhes, diarrhea, leathery, sleep and coma. 
Body Weight:  
Individual weight of animals was determined before the test substance was 
administered and weights will be recorded at day 1, 7, and 14 of the study. Weight changes 
were calculated and recorded. At the end of the test, surviving animals were weighed and 
humanly killed.Table- 8. 
 
 
Food and water Consumption: 
 Food and water consumed per animal was calculated for control and the treated dose 
groups. Table: 9-10. 
Mortality: 
Animals were observed for mortality throughout the entire period. 
Results: 
 All data were summarized in tabular form Table- 11. 
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5.2 REPEATED DOSE 28-DAYS ORAL TOXICITY STUDY OF KALLADAIPPU 
THOOL(OECD GUIDELINE – 407) 
Sub-acute toxicity study was carried out according to OECD 407 and rats were 
divided into 4 groups of 10 animals (5 male and 5 female). Kalladaippu Thool with tender 
coconut water was administered to rats at the dose of 140 mg/kg,700mg /kg/day and 
1400mg/kg/day continuously for 28 days. The animals were observed daily for gross 
behavioural changes and other sign of sub-acute toxicity. The weight of the each rat was 
recorded on day 0 and weekly throughout the course of the study, food and water 
consumption per rat was calculated. At the end of 28 days they were fasted overnight ,each 
animal were anaesthetized with diethyl ether  and blood samples were collected from the 
retro-orbital plexus into two tubes: one with EDTA for immediate analysis of hematological 
parameters, the other without any anticoagulant and was centrifuged at 4000 rpm at 4 °C for 
10 minutes to obtain the serum. Serum was stored at 20 °C until analyzed for biochemical 
parameters. 
 
Test Substance  :Kalladaippu Thool 
Animal Source  :TANUVAS,Madhavaram, Chennai.   
Animals   :Male and Female Wister Albino Rats 
Age    :6-8 weeks 
Body Weight  :150-200gm. 
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Acclimatization  :Seven days prior to dose. 
Veterinary examination :Prior and at the end of the acclimatization period. 
Identification of animals :Bycage number, animal number and individual  
 marking by using    Picric acid 
Diet    :Pellet feed supplied by Sai meera foods Pvt Ltd,        
    Bangalore 
Water    :Aqua guard portable water in polypropylene bottles. 
Housing & Environment :The animals were housed in Polypropylene cages   
    provided with bedding of husk. 
Housing temperature : between 22ºC + 3ºC.  
Relative humidity  :between 30% and 70%, 
Air changes    :10 to 15 per hour  
Dark and light cycle   :12:12 hours. 
Duration of the study :28 Days. 
 
Justification for Dose Selection: 
The results of acute toxicity study in rats indicated that Kalladaippu Thoolwas 
nontoxic and no behavioral changes were observed up to the dose level of 2000mg/kg body 
weight. The oral route was selected for use because oral route is considered to be a proposed 
therapeutic route. 
Preparation and Administration of Dose: 
Kalladaippu Thoolwas suspended in with Tender coconut water. It was administered 
to animals at three doses level 140mg/kg,700 mg/kg and 1400 mg/kg respectively were 
prepared. The test substance was prepared every two days once for 28 days. The control 
animals were administered vehicle only. The drug was administered orally by using oral 
gavage oncedaily for 28 consecutive days. 
Methodology: 
Randomization, Numbering and Grouping of Animals: 
 The rats randomly divided into four groups in each group consist of 10 rats (5male 
and 5 female) dosing up to 28 days. Animals‟ acclimatization period of 7 days to laboratory 
conditions prior to the initiation of treatment. Each animal was fur marked with picric acid. 
The females were nulliparous and non-pregnant. 
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Observations: 
Experimental animals were kept under observation throughout the course of study for 
the following: 
i) Body Weight: 
Weight of each rat was recorded on day 0 and at weekly intervals throughout the course 
of study and at termination to calculate relative organ weights. From the data, group mean 
body weights and percentage of body weight gain was calculated in Table- 12. 
ii) Food and water Consumption: 
The quantity of food consumed by groups consisting of ten animals for different doses 
was recorded at weekly interval. Food and consumed per animal was calculated for control 
and the treated dose groups. Table: 13-14. 
iii) Clinical signs: 
All animals were observed daily for clinical signs. The time of onset, intensity and 
duration of these symptoms, if any, were recorded. 
iv) Mortality: 
All animals were observed twice daily for mortality during entire course of study. 
v) Laboratory investigation: 
Following laboratory investigations were carried out on 29
th
 day in animals fasted 
over-night. Blood samples were collected from orbital sinus using sodium heparin 
(200IU/ml) for Bio chemistry and potassium EDTA (1.5 mg/ml) for Hematology as 
anticoagulant. Blood samples were centrifuged at 3000 r.p.m. for 10 minutes. 
vi) Hematological Investigations: 
Haematological parameters were determined by using Haematology analyzer.  
vii) Biochemical Investigations: 
              Biochemical parameters were determined by using auto-analyzer. 
ix) Histopathology:  
Control and highest dose group animals were subjected to histopathological investigations. If 
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any abnormality found in the highest dose group than the low, then the mid dose groupalso be 
examined. Organs were collected from all animals and preserved in 10% buffered neutral 
formalin for 24 h and washed in running water for 24 h.  The organ sliced 5 or 6µm sections 
and were dehydrated in an auto technicon and then cleared in benzene to remove absolute 
alcohol. Embedding was done by passing the cleared samples through three cups containing 
molten paraffin at 50°C and then in a cubical block of paraffin made by the “L” moulds. It 
was followed by microtome and the slides were stained withHaematoxylin-eosin. 
Statistical analysis: 
Findings such as clinical signs of intoxication, body weight changes, food 
consumption, and hematology and blood chemistry were subjected to One-way Anova 
Followed by Dunnet‟s test using a computer software programme. All data were summarized 
in tabular form (Table: 15-18). 
5.3. REPEATED DOSE 90-DAYS ORAL TOXICITY STUDY 
OFKALLADAIPPUTHOOL (OECD GUIDELINE – 408) 
 
Test Substance  : Kalladaippu Thool 
Animal Source  : TANUVAS,Madhavaram, Chennai. 
Animals   : Wister Albino Rats (Male -3, and Female-3) 
Age    :6-8 weeks 
Body Weight   :150-200gm. 
Acclimatization  :Seven days prior to dosing. 
Veterinary examination :Prior and at the end of the acclimatization period. 
Identification of animals :Bycage number, animal number   and    individual  
  marking by using picric acid.      
Diet    :Pellet feed supplied by Sai meera foods Pvt Ltd,        
  Bangalore 
Water    :Aqua guard portable water in polypropylene bottles. 
Housing & Environment : The animals were housed in Polypropylene cages   
   provided with bedding of husk. 
Housing temperature :between 22ºC +3ºC.  
Relative humidity  :between 30% and 70%, 
Air changes    :10 to 15 per hour  
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Dark and light cycle   : 12:12 hours. 
Duration of the study : 90 Days. 
 
Methodology: 
Randomization, Numbering and Grouping of Animals: 
24 Wistar Albino Rats (12M + 12F) were selected and divided into 4 groups. Each 
group consists of 6 animals (Male-3 and Female-3)IAEC approval to 
IAEC/XLIX/18/CLBMCP/2016.I
st
 group treated as a control and other three group were 
treated with test drug (low, mid, high) for 90 days. Animals were allowed acclimatization 
period of 7 days to laboratory conditions prior to the initiation of treatment. Each animal was 
marked with picric acid. The females were nulliparous and non-pregnant. 
 
 
 Justification for Dose Selection: 
As per OECD guideline three dose levels were selected for the study. They were low 
dose (X), mid dose dose (5X), high dose (10X). X is calculated by multiplying the therapeutic 
dose (8gm) and the body surface area of the rat (0.018). i.e X dose is 140 mg/kg, 5X dose is 
700mg/kg and 10 X dose is 1400 mg/kg of animal. 
 
Preparation and Administration of Dose: 
Kalladaippu Thoolwas suspended in tender coconut water to obtain concentrations of 
200mg/ml. It was administered to animals at the dose levels of 140 mg/kg, 700 mg/kg and 
1400 mg/kg. The test substance suspensions were freshly prepared every two days once for 
90 days. The control animals were administered vehicle only. The drug was administered 
orally by using oral gavage once daily for 90 consecutive days. 
Observations: 
Experimental animals were kept under observation throughout the course of study for 
the following: 
Body Weight: 
Weight of each rat was recorded on day 0, at weekly intervals throughout the course 
of study .Table – 21. 
Clinical signs: 
67 
 
All animals were observed daily for clinical signs. The time of onset, intensity and 
duration of these symptoms, if any, were recorded. 
 
Mortality: 
All animals were observed twice daily for mortality during entire course of   study. 
Laboratory Investigations: 
Following laboratory investigations were carried out on day 91 in animals‟ fasted 
over-night. Blood samples were collected from orbital sinus using sodium heparin 
(200IU/ml) for Bio chemistry and potassium EDTA (1.5 mg/ml) for Hematology as 
anticoagulant. Blood samples were centrifuged at 3000 r.p.m. for 10 minutes. 
 
Hematological Investigations: 
Hematological parameters were determined using Hematology analyzer. 
Biochemical Investigations: 
 Biochemical parameters were determined using auto-analyzer. 
Histopathology: 
Control and highest dose group animals will be initially subjected to histopathological 
investigations. If any abnormality found in the highest dose group than the low, then the mid 
dose group will also be examined. Organs will be collected from all animals and preserved in 
10% buffered neutral formalin for 24 h and washed in running water for 24 h.  The organ 
sliced 5 or 6µm sections and were dehydrated in an auto technicon and then cleared in 
benzene to remove absolute alcohol. Embedding was done by passing the cleared samples 
through three cups containing molten paraffin at 50°C and then in a cubical block of paraffin 
made by the “L” moulds. It was followed by microtome and the slides were stained 
withHaematoxylin-eosin. 
Statistical analysis: 
Findings such as clinical signs of intoxication, body weight changes, hematology and 
blood chemistry were subjected to One-way ANOVA followed by dunnett‟stest using a 
computer software programme -INSTAT-V3 version.All data were summarized in Table-19 
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to 24. 
 
 
 
 
 
 
 
6.1 ANTI-UROTHIALITIC ACTIVITY OF KALLADAIPPU THOOL 
Aim:  
 Screening ofKalladaippu Thoolagainst ethylene glycol inducedUrolithiasis in Wister 
albino rats. 
Experimental animals: 
Healthy adult Wister albino male rats of weighing 150-200gm were included in the 
study. The animals were procured from the animal house of TANUVAS, Madhavaram, 
Chennai. The animals were maintained in well ventilated room temperature with natural 12 
+12hrs light/dark cycle in the polypropylene cages. The animals were fed with balanced diet 
that is standard rodent pellet diet Sai meera foods Pvt Ltd, Bangalore and water ad libitum. 
The animals were housed for 1week prior to the experiment to acclimate to the laboratory 
conditions. Approval for the research work and ethical clearance was obtained from 
Institutional Animal Ethical Committee (IAEC/XLIX/18/CLBMCP/2016).  
Animal grouping: 
Wistar albino male rats of body weight ranging from 150-200gm were used as 
experimental animals. They were divided into six groups (6 per group) as follows: 
Group I : Normal Control (vehicle) 
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Group II : Lithiatic Control (ethylene glycol) +vehicle 
Group II : Treated with Standard (ethylene glycol +Cystone) 
Group IV : Treated with Kalladaippu Thool (100mg/kg) + ethylene glycol 
Group V : Treated with Kalladaippu Thool (200mg/kg) + ethylene glycol 
Group VI : Treated with Kalladaippu Thool (400 mg/kg) + ethylene glycol 
Pharmacological screening for anti- Urolithiatic activity :
( 24) 
Animals were divided into six groups containing six animals in each. Group I served 
as control and received regular rat food and drinking water ad libitum. Ethylene glycol 
(0.75%) in drinking water was fed to Groups II to Group VI for induction of renal calculi till 
28 days.  Group II received Ethylene glycol alone and served as lithiatic control. Group III 
received standard anti-urolithiatic drug, Cystone (750mg/kg body weight) from 15
th
 day to 
end of the study period. Groups IV, Group V and Group VI received Kalladaippu Thool (100, 
200 and 400 mg/kg body weight respectively) from 15
th
 day to 28
th
 day of the study period. 
All drugs were administered once daily through oral route by using gastric tube.  
On 29
th 
day animals of all the groups were kept in metabolic cages and urine samples 
were collected for 24h and analyzed for calcium, potassium and oxalate content. The serum 
analysed for blood urea nitrogen, uric acid and creatinine. 
Statistical analysis: 
 
The results were expressed as mean ±SEM (n=6). Statistical analysis was performed 
by ANOVA test for multiple comparisons followed by Dunnett‟s test and P<0.05 was 
considered as significant. 
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6.2. DIURETIC AND 6.3 SALURETIC ACTIVITY OF KALLADAIPPU THOOL 
Aim: 
 To evaluate the diuretic and saluretic potential
(26)
 of Kalladaippu Thoolin 
Wisteralbino rats. 
Experimental animals: 
Healthy adult Wister albino male rats of weighing 150-200gm were included in the 
study. The animals were procured from the animal house of TANUVAS, Madhavaram, 
Chennai. The animals were maintained in well ventilated room temperature with natural 12 
+12hrs light/dark cycle in the polypropylene cages. The animals were fed with balanced diet 
that is standard rodent pellet diet Sai meera foods Pvt Ltd, Bangalore and water ad libitum. 
The animals were housed for 1week prior to the experiment to acclimate to the laboratory 
conditions. Approval for the research work and ethical clearance is obtained from 
Institutional Animal Ethical Committee (IAEC/XLIX/18/CLBMCP/2016). 
Study design:
 (25) 
Wistar rats were divided into five groups of six rats in the Group (I) served as normal 
control (Vehicle). Group II received as furosemide (20mg/kg). Groups (III) to Group (V) 
received Kalladaippu Thool respectively at dose of 100mg/kg, 200 mg/kg and 400 mg/kg 
orally and immediately after the extract treatment, all the rats are hydrated with saline (15 
ml/kg) and placed in metabolic cages. A total volume of urine collected for 24h was 
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measured at the end. During this period no food and water were made available to 
animals.The urine volume (ml/day) was measured and then assayed for Na
+
, K
+
and Cl
-
concentrations in mMol/l, Cl
-
 was measured by using routine method.
 
Procedure: 
The method of Lipschitz et al
(27)
 employed for the assessment of diuretic activity. All 
the animals were hydrated with double distilled water. Food and water were withdrawn 8h 
before the administration of drug. Immediately after dosing, all the animals were placed 
individually in metabolic cages and urine passed by the animals over a period of 24 h was 
collected in a conical flask. Total urine, urinary output, urinary electrolyte, Ph was 
determined. 
Estimation of urine output: 
Metabolic cage is designed with a stainless steel circular frame. The upper portion is 
covered with a lid, provided with a wire mesh bottom and a funnel for collecting the urine. 
Stainless steel sieves were placed in the funnel to retain the faeces, allowing only urine to 
flow down for collection and measurement. The whole structure is fixed to a metal frame, 
which keeps the frame in upright position. Conical flask is kept to collect the urine at the 
bottom exit of the funnel for a period of 24h.Urine volume is expressed as ml/kg. The room 
temperature is maintained at 27-29°c. 
Assessment of lipschitz-value and saluretic effect: 
 
The mean urine volume was determined and it was expressed as Lipschitz-value, i.e., 
the ratio of T/C in which T was the response of the test compound and C that of control. 
Indices of 1.0 and more were regarded as positive effect. The saliuretic activity (Na
+
+Cl
-
) and 
natriuretic activity (Na
+
 /K
+
) of the test extracts was also calculated. The index values greater 
than 2.0 indicate favourable natriuretic effect. The diuretic potency and the saluretic effect 
were assessed by comparison of the urinary excretion and urinary electrolyte excretion 
respectivelyof the test extracts with respect to the control group. 
Statistical analysis: 
All values are expressed as mean values ± SEM (Standard error of mean) and data 
were analyzed by applying an analysis of variance (ANOVA) followed by dunnett‟s t test. 
The results were considered statistically significant if P < 0.05. 
72 
 
 
  
73 
 
7.  RESULTS 
ORGANOLEPTIC CHARACTERS 
Table 1:Organoleptic characters of Kalladaippu Thool 
      Color        Dark Brown 
      Odour        Pleasant 
      Taste        Salty  
      Texture        Fine powder 
 
PHYSICOCHEMICAL ANALYSIS 
Table 2: Physicochemical properties of Kalladaippu Thool 
 
 
S. No. 
 
Parameters 
 
Results 
 
1 
 
Loss on drying 
 
1.338% 
2 Ash value  
a. Total ash (w/w) 
b. Acid insoluble ash (w/w) 
c. Water Soluble ash (w/w) 
 
                      0.282% 
                      0.028% 
                      0.086% 
 
3 
 
Extractive values  
a. Alcohol soluble (w/v) 
b. Alcohol successive soluble (w/v) 
 
                      3.87% 
                      2.94% 
 
4 
 
pH values (10% solution) 
 
  9.8 
 
*The experimental procedure was analyzed at Regional Research Institute of Unani 
Medicine (RRIUM), Rayapuram, Chennai- 600 013. 
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CHEMICAL ANALYSIS 
 Table 3:   Results of acid radicals studies of Kalladaippu Thool* 
S.NO Parameter  
Observation 
Result 
1 Test for Sulphate Cloudy appearance 
present 
Positive 
2 Test for Chloride - Negative 
3 Test For Phosphate - Negative 
4 Test For Carbonate - Negative 
5 Test For Nitrate - Negative 
6 Test for Sulphide - Negative 
7 Test For Fluride &oxalate - Negative 
8 Test For Nitrite - Negative 
9 Test For Borax - Negative 
 
Interpretation: 
 The acidic radicals test shows the presence of Sulphate. 
 
*The chemical analysis was carried out in Bio chemistry Lab, NIS, Chennai – 47. 
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Table 4:   Results of basic radicals studies of Kalladaippu Thool* 
S.NO Parameter Observation Result 
1 Test for Lead - Negative 
2 Test for Copper - Negative 
3 Test For Aluminium - Negative 
4 Test For Iron Blood red color appeared Positive 
5 Test For Zinc - Negative 
6 Test for Calcium Cloudy appearance and white 
precipitate was obtained 
Positive 
7 Test For Magnesium - Negative 
8 Test For Ammonium - Negative 
9 Test For Potassium - Negative 
10  Test For Sodium - Negative 
11 Test For Mercury - Negative 
12 Test For Arsenic - Negative 
 
Interpretation: 
 The basic radical test shows the presence of Iron, Calciumand absence of heavy 
metals such as lead, arsenic and mercury. 
*The chemical analysis was carried out in Bio chemistry Lab, National Institute of Siddha, 
Chennai- 47. 
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TLC AND HPTLC ANALYSIS OF KALLADAIPPU THOOL 
The procedure recommended for the analysis of TLC and HPTLC analysis as per 
Wagner H and Bladt S, 1996 
Instrument Details:  
Name of the Instrument : CAMAG (CAMAG - Automatic TLC sampler, 
   Scanner and Visualizer) 
Spray Gas : N2 
Lamp used : Deuterium and Tungsten Lamp 
 
The sample was applied for the Thin Layer Chromatography and High Performance 
Thin Layer Chromatography study with suitable solvent systems.  After development the 
plate was allowed to dry in air and examined under UV – 254nm, 366nm and visible light 
after derivatised using vanillin – sulphuric acid.   
The sample (alcohol extract - 20µl) was applied in TLC aluminium sheet silica gel 60 F 
254 (E. MERCK) and plate was developed using the solvent system Toluene: Ethyl acetate: 
Formic acid (8: 2: 0.2). After development the plate was allowed to dry in air and examined 
under UV – 254 nm, 366 nm and Visible light (Vanillin –Sulphuric acid).   
 
 
 
 
UV-254 nm 
 
 
UV- 366 nm 
Visible light  
(Derivatized with 
Vanillin-Sulphuric acid) 
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Table 5: Rf values 
 
Solvent Systems 
 
Rf values 
 
UV- 254 nm 
 
UV- 366 nm 
 
Visible light 
(Vanillin –
Sulphuric acid) 
 
Toluene : Ethyl acetate : 
Formic acid  (8 : 2 : 0.2) 
0.73 Dark green 0.90 Light yellow 0.60 Brown 
0.59 Dark green  0.79 Light blue 0.46 Red 
0.46 Dark green 0.70 Dark blue  
 0.62 Dark blue  
 0.48 Dark blue  
 0.19 Blue  
 
 
 
 
 
 
 
 
 Densitometric chromatogram at UV-254 nm 
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 Densitometric chromatogram at UV-366 nm 
 
HPTLC finger print at UV-254 nm 
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HPTLC finger print of Aflatoxin standards at UV-366 nm 
HPTLC finger print at UV-366 nm 
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HEAVY METAL ANALYSIS AND MICROBIAL LOAD ANALYSIS 
Table 6: Test for Heavy Metals: 
S. 
No. 
Heavy 
metal 
Reference Limits  
as per API- Vol.-I 
Results Remarks 
1 Lead Not more than 10ppm 0.1393ppm Within permissible limits 
2 Arsenic Not more than 3.0ppm  18.1075ppb Within permissible limits 
3 Cadmium Not more than 0.3ppm 0.0043ppm Within permissible limits 
4 Mercury Not more than 1.0ppm 6.9876ppb Within permissible limits 
 
Table 7:  Analysis of Microbial Load: 
S. No. Parameters Reference Limits 
as per WHO 
(2007) 
Results Remarks 
1 Total Bacterial Count (TBC) 10
5
CFU/gm Less than 10 
cfu/gram 
 
 
 
Within 
permissible 
limits 
2 Total Fungal Count (TFC) 10
3
CFU/gm Absent  
3 Enterobacteriaceae 10
3
 Absent 
4 Escherichia coli 10 Absent 
5 Salmonella Spp  Absent Absent 
6 Staphylococcus aureus Absent Absent 
 
 Test For Aflatoxin: 
  
 
UV-366nm 
 
Standard – G2, G1, B2 & B1  
The test sample does not show the evidence for the presence of any of 
the aflatoxins.   
Densitometric chromatogram at UV-366nm 
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XRD STUDY RESULTS 
XRD (image) 
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Background and intensity filtered 
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Peak (detected) 
Angle d value Intensity Intensity % 
2-Theta ° Angstrom Count % 
20.207 4.39107 37.5 3.2 
21.666 4.09847 79.4 6.8 
24.196 3.67538 60.4 5.2 
26.590 3.34963 87.1 7.5 
27.236 3.27167 203 17.4 
28.307 3.15027 669 57.3 
29.349 3.04069 244 21.0 
30.317 2.94586 248 21.3 
31.389 2.84757 486 41.7 
31.663 2.82362 1167 100.0 
40.476 2.22683 453 38.8 
41.148 2.19201 44.6 3.8 
44.223 2.04645 181 15.5 
45.359 1.99779 416 35.7 
48.440 1.87766 47.7 4.1 
50.145 1.81775 138 11.8 
55.233 1.66173 67.4 5.8 
56.367 1.63095 137 11.7 
58.605 1.57390 67.1 5.8 
66.321 1.40825 179 15.3 
75.174 1.26286 115 9.9 
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Peak (image) 
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Acute Oral Toxicity Study of Kalladaippu Thool 
Table: 8Body weights of Wistar albino rats groups exposed toKalladaippu thool 
N.S- Not Significant,**(p > 0.01), *(p >0.05), n = 10 values are mean ± S.D (One-way 
ANOVA followed by Dunnett‟s test) 
 
Table: 9Water intakes (ml/day) of Wistar albino rats group exposed toKalladaippu   
Thool 
DOSE 
 
DAYS 
1 6 14 
Control 54 ± 3.20 54.1±6.10 54.3±5.44 
High dose 53.5±1.30 53.8±6.70 54.2±5.64 
P value (p)* NS NS NS 
N.S- Not Significant,**(p > 0.01), *(p >0.05), n = 10 values are mean ± S.D (One-way 
ANOVA followed by Dunnett‟s test) 
 
Table 10: Food intake (gm/day) of Wistar albino rats group exposed to kalladaippu thool 
DOSE 
 
DAYS 
1 7 14 
Control 56.03±2.82 56.2±2.96 57.7±8.86 
High ose 58.6±5.44 58.4±5.20 59.8±6.67 
P value (p)* NS NS NS 
 
 
DOSE 
 
 
DAYS 
 1 7 14 
Control 158.1±65.70  158.4 ± 41.11 159.7 ±02.12 
High dose 157.1± 6.64 157.4 ±7.42 158.8 ± 2.70 
P value (p)* NS NS NS 
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Table 11: Dose finding experiment and its behavioural Signs of Toxicity in wistar albino 
rats  
No Dose 
mg/kg 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 
1 Control + - - - - + - - - - - - - - - - - - - - 
2 2000 + - - - - + - - - - - - - - - - - - - - 
 
1.Alertness 2.Aggressiveness 3.Pile erection 4.Grooming 5.Gripping 6.Touch Response 
7.Decreased Motor activity 8.Tremors 9.Convulsions 10.Muscle Spasm 11.catatonia 
12.Muscle relaxant 13.Hypnosis 14.Analgesia 15.Lacrimation 16.Exophthalmos 17.Diarrhoea 
18. Writhing 19.Respiration 20.Mortality 
+ Presence of Activity 
-Absence of Activity 
Result 
All the data were summarized in the form of Table - 11 revealed no abnormal signs 
and behavioral changes in rats upto the dose level of 2000 mg/kg body weight administered 
orally. 
 
 
 
 
 
*Acute oral toxicity was done at C.L Baid Metha college of Pharmacy, Thoraipakam, 
Chennai-97. 
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28 Days Repeated Dose Oral Toxicity Study of Kalladaippu Thool 
Table 12: Body weight grams of wistar albino rats exposed to KalladaippuThool for 28 
days 
Dose 
(mg/kg/day) 
Days 
0 7 14 21 28 
Control 157±4.37 157.42±1.17 156.92±1.21 157.36±1.41 158.01±1.03 
Mid dose 154.13±0.82 154.72±0.55 155.24±0.98 156.1±1.17 157.12±0.52 
High dose 155.8±1.03 156.12±0.75 156.69±0.89 157.22±0.75 158.11±1.52 
Values are mean of 10 animals ± S.E.M (Dunnett‟s test) *p<0.05;**p<0.01.N=10 
Table 13: Water (ml/day) intakes of wistar albino rats exposed to Kalladaippu Thool for 
28 days 
Dose(mg/kg/day) Days 
1 7 14 21 28 
Control 32.0±0.92 33.36±0.23 33.23±0.23 33.18±0.16 33.64±0.38 
Mid dose 35.83±0.49 34.5±1.52 34.33±1.51 35.5±1.05 35.83±1.72 
High dose 34.72±1.51 35.19±1.79 36.17±1.51 36.42±1.33 36.59±1.52 
Values are mean of 10 animals ± S.E.M (Dunnett‟s test) *p<0.05;**p<0.01.N=10 
Table14: Food (g/day) intakes of wistar albino rats exposed to Kalladaippu Thool for 28 
days 
Dose 
(mg/kg/day) 
Days (gms/rats) 
1 7 14 21 28 
Control 33.5±0.84 34.72±1.17 35±0.75 35.32±1.97 35.86±1.37 
Mid dose 35.82±0.82 38.16±0.75 38.02±0.98 39.83±1.60 39.33±1.21 
High dose 34.75±2.02 37.13±1.33 37.93±1.10 39.33±1.51 39.83±1.17 
 Values are mean of 10 animals ± S.E.M (Dunnett‟s test)* p<0.05;**p<0.01.N=10 
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Table: 15 Hematological parameters after 28days treatment with Kalladaippu Thoolin 
wistar albino rats 
Category Control Low dose Mid dose High dose P value 
(p)* 
Haemoglobin 
(g/dl) 
14.5±0.43 14.60±0.32 14.8±0.23 14.84±0.33 N.S 
Total WBC 
 (×10
3   
l) 
12.71±0.40 12.82±0.21 12.94±0.60 13.06±1.40 N.S 
Neutrophils (%) 26.12±0.40 25.22±0.32 26.31±1.50 26.54±2.20 N.S 
Lymphocyte (%) 80.12±1.60 80.74±1.40 81.16±1.44 81.70±1.64 N.S 
Monocyte (%) 0.6±0.02 0.56±0.01 0.72±0.04 0.75±0.03 N.S 
Eosinophil (%) 0.21±0.02 0.19±0.04 0.23±0.06 0.26±0.06 N.S 
Platelets 
cells10
3
/µl 
702±2.28 702.32±2.42 702.21±2.60 702.42±3.64 N.S 
Total RBC 10
6
/µl 7.64±0.32 7.65±0.32 7.75±0.04 7.9±0.06 N.S 
PCV% 40.30±0.4 40.32±5.30 40.5±2.70 41.2±1.22 N.S 
MCHC g/dL 34.7±1.61 33.8±1.32 34.8±1.35 34.93±1.36 N.S 
MCV fL(µm
3
) 52.7±3.04 52.2±2.40 51.9±2.20 52.4±1.20 N.S 
Values are mean of a 10 animals ± S.E.M (Dunnett‟s test)* p<0.05;**p<0.01.N=10 
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Chart 1: The mean value of T.WBC of control and treated groups of wistar albino rats 
exposed to Kalladaippu Thool 
 
 
Chart 2: The mean value of Hb and T.RBC of control and treated groups of wistar 
albino rats exposed to Kalladaippu Thool 
 
 
12.5
12.6
12.7
12.8
12.9
13
13.1
Control Low dose Mid dose High dose
T.WBC
T.WBC
0
2
4
6
8
10
12
14
16
Control Low dose Mid dose High dose
Hb
RBC
94 
 
Chart 3:The mean value of Platelet of control and treated groups of wistar albino rats 
exposed to Kalladaippu Thool for 28 days 
 
 
Chart 4:  The mean value of Neutrophils and Lymphocytes of control and treated 
groups of wistar albino rats exposed to Kalladaippu Thoolfor 28 days 
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Chart 5:  The mean value of Monocytes and Eosinophils of control and treated groups 
of wistar albino rats exposed to Kalladaippu Thool for 28 days 
 
 
Chart 6:  The mean value of PCV, MCHC and MCV of control and treated groups of 
wistar albino rats exposed to Kalladaippu Thool for 28 days 
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Table: 16 Effect of treatment with Kalladaippu Thool on biochemical parameters 
Biochemical 
Parameters 
Control Low dose Mid dose High dose P Value 
(p)* 
Glucose (R) (mg/dl) 98.10±2.40 98.12±1.62 98.56±.08 99±5.25 N.S 
Cholesterol(mg/dl) 109.14±3.10 109.25±2.40 109.30±1.58 110.21±1.60 N.S 
 TGL(mg/dl) 73.05±1.08 73.11±1.02 73.25±1.42 75.26±1.54 N.S 
LDL 58.5±4.13 58.1±1.05 57.3±1.03     58.40±2.44 NS 
VLDL 15.2±1.30 15.10±1.71 15.22±1.62 15.24±1.55 NS 
HDL 32.22±2.30 31.22±2.60 32.46±1.72 33.56±1.43 NS 
Ratio 1(T.CHO/HDL) 3.38±1.10 3.49±1.20 3.36±2.32 3.28±2.63 NS 
Ratio 2(LDL/HDL) 
 
1.81±2.33 1.86±1.40 1.76±2.10 1.74±04.02 NS 
Albumin (g/dL) 4.12±0.50 3.9±0.54 4.25±4.20 4.76±3.24 NS 
 T. Protein(g/dl) 6.9±0.14 6.9±0.41 7.00±0.60 7.2±0.41 N.S 
NS- Not Significant,** (p > 0.01), * (p >0.05), n = 10 values are mean ± S.D (One way 
ANOVA followed by Dunnett‟s test) 
Chart 7:The mean value of Blood sugar of control and treated groups of wistar albino 
rats exposed to Kalladaippu Thoolfor 28 days 
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Chart 8: The mean value ofTotal Cholesterol and Triglyceride of control and treated 
groups of wistar albino rats exposed to Kalladaippu Thoolfor 28 days 
 
 
Chart 9: The mean value of HDL,LDL and VLDL of control and treated groups of 
wistar albino rats exposed to Kalladaippu Thoolfor 28 days 
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Chart 10: The mean value of Albumin and Total Protein of control and treated groups 
of wistar albino rats exposed to Kalladaippu Thoolfor 28 days 
 
 
Table 17: Renal function test of Wistar albino rats group exposed to Kalladaippu 
Thoolfor 28 days 
Parameters Control Low Dose Mid Dose High Dose PValue 
(p)* 
Urea (mg/dl) 24.31±0.1 24.10±0.19 23.26±1.28 22.34±1.02 N.S 
Creatinine(mg/dl) 0.7±0.04 0.71±0.06 0.62±0.04 0.68±0.08 N.S 
BUN(mg/dL) 16.8±0.04 16.1±0.24 15.4±0.42 14.9±1.02 NS 
Uric acid(mg/dl) 5.04±0.02 5.03±0.20 4.9±0.32 4.2±0.20 N.S 
NS- Not Significant, ** (p > 0.01), * (p >0.05) , n = 10 values are mean ± S.D (One way 
ANOVA followed by Dunnett‟s test) 
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Chart 11: The mean value of Urea, Creatinine, blood urea nitrogen and uric acid of 
control and treated groups of wistar albino rats exposed to Kalladaippu Thoolfor 28 
days 
 
 
Table 18: Liver Function Test of Wistar albino rats group exposed to Kalladaippu 
Thoolfor 28 days 
Parameters Control Low Dose Mid Dose High Dose P Value 
(p)*  
T. Bilirubin (mg/dl). 0.2±0.01 0.24±0.03 0.21±0.03 0.24±0.01 N.S 
SGOT/AST(U/L) 15.43.11±1.43 15.12±0.62 14.87±1.34 15.87±1.63 N.S 
SGPT/ALT(U/L) 46.11±1.43 46.24±1.14 48.44±1.36 48.23±0.21 N.S 
ALP(U/L) 46.30±2.11 46.1±2.10 45.65±1.14 45.98±2.01 N.S 
 
NS- Not Significant, ** (p > 0.01), * (p >0.05), n = 10 values are mean ± S.D (One way 
ANOVA followed by Dunnett‟s test 
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Chart 12:The mean value of Total Bilirubin of control and treated groups of wistar 
albino rats exposed to Kalladaippu Thoolfor 28 days 
 
 
Chart 13:The mean value of ALP,SGOT and SGPT of control and treated groups of 
wistar albino rats exposed toKalladaippu Thool for 28 days 
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HISTOPATHOLOGICAL EXAMINATION 
28-Days repeated dose oral toxicity study of Kalladaippu Thool 
BRAIN 
Control     High Dose 
   
HEART 
Control     High Dose 
 
     
KIDNEY 
Control     High Dose 
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LIVER 
Control     High Dose 
 
 SPLEEN 
Control     High Dose 
 
   
Interpretation: 
 The above slides show the histopathology studies of sub-acute toxicity. There is no 
toxicological abnormality seen in the vital organs after administration of the test drug 
Kalladaippu Thool. Thus the safety of the drug is revealed so that it can be administered for 
long time without any side effects. 
 
Results of Repeated Dose 28 Days Oral Toxicity Study: 
Repeated dose 28 days oral toxicity of Kalladaippu Thoolon rats were conducted. All 
animals from the treated dose survived throughout the dosing period of 28 days. Various 
parameters were studied and the interpretation of the study result was discussed below. 
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Clinical signs: 
No abnormal behavioural signs were observed during the study period. 
Mortality: 
The test drug “Kalladaippu Thool” did not cause any mortality in mid and high dose 
levels and were considered as safe dose levels.  
Body weight: 
The result of the body weight of rats exposed to control and the trial drug of different 
dose groups exhibited over all mild weight gain throughout the dosing period of 28 days. The 
quantity of food taken by the animals from different dose groups and the control is 
comparably normal. 
Hematological investigation interpretation: 
The hematological investigation results of the rats conducted on 29th day after the 
repeated dose of the drug revealed the values of different parameters. The increase and 
decrease in the values obtained were all within the normal biological and laboratory limits. 
Biochemical investigation interpretation: 
The biochemical investigations were conducted on 29th day and the result was 
produced. The results revealed there were no significant changes in the values of different 
parameters with that of the control. All the values were within the normal biological and 
laboratory limits. 
Histopathology interpretation: 
 Histopathological study of the organ such as brain, heart, kidney, liver and spleen 
were normal in control and all test groups. 
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90 Days Repeated Dose Oral Toxicity Study of Kalladaippu Thool 
Table 19: Body weight of wistar albino rats exposed to Kalladaippu Thoolfor 90 days 
 
NS- Not Significant, ** (p < 0.01),*(p <0.05), N = 6; values are mean ± S.D (One way 
ANOVA followed by Dunnett‟s test. 
 
 
 
 
 
 
 
 
 
 
 
DAYS Weight(gms)/Days P value 
(p)
* 
Control Low dose Mid dose High dose 
1 161.6±33.68 148.1 ± 21.11 156.6± 13.57 159.5±28.75 NS 
15 172.8 ± 28.87 162.5 ± 21.71 166.7 ± 29.01 166.8±32.13 NS 
30 181.8 ± 28.31 175.71 ± 14.88 181.8 ± 32.11 181± 28.94 NS 
45 204.5± 27.73 194.5± 29.76 204.7± 19.75 208.3± 22.75 NS 
60 218.6±33.68  214.6±23.68 226.6±33.68  215.6±23.78 NS 
75 236.8 ± 26.85 226.8 ± 28.87 241.8± 28.87 224.8 ±26.87 NS 
90 248.5± 27.32 239.5± 27.68 251.4± 27.32 236.3± 36.32
 
NS 
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Table 20: Hematological parameters of Wistar albino rats group exposed toKalladaippu 
Thoolfor 90 days 
Category Control Low dose Mid dose High dose P value 
(p)* 
Hemoglobin(g/dl) 12.53±0.31 12.7±0.59 12.63±0.45 12.78±0.67 N.S 
Total WBC 
(cells/cu.mm) 
11.2±4.02 11±0.54 11.15±5.12 11.4±6.37 N.S 
Neutrophils (%) 28.32±0.02 28.23±0.40 28.25±5.24 28.35±2.52 N.S 
Lymphocytes (%) 89.12±1.41 89.04±1.42 89.6±1.74 89.7±1.46 N.S 
Monocyte (%) 0.1±0.02 0.15±0.04 0.2±0.06 0.22±0.07 N.S 
Eosinophils (%) 0.02±0.01 0.02±0.05 0.03±0.01 0.02±0.02 N.S 
Platelets lakhs/µl 351±.21 367±25 387.05±26 36±33 N.S 
Total RBC 
(cells/cu.mm) 
7.25±0.3 7.08±0.3 7.13±0.2 7.16±0.3 N.S 
PCV% 37.59±0.95 38.29±0.18 37.9±1.34 38.36±2.05 N.S 
MCHC g/dl 30±3.03 33.66±1.86 31±1.22 30.5±0.07 N.S 
MCV%ft 92.16±2.62 91.3±3.75 92.3±1.98 91.5±1.89 N.S 
MCH pg. 30± 3.03 32.75±1.86 31±1.22 30.5±0.07 N.S 
 
N.S- Not Significant, ** (p < 0.01), *(p <0.05), n = 6 values are mean ± S.D (One way    
ANOVA followed by Dunnett‟s test). 
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Chart 14: The mean value of HB, Total RBC, Total WBC of control and treated groups 
of wistar albino rats exposed to Kalladaippu Thoolfor 90 days 
 
Chart 15: The mean value of Platelets of control and treated groups of wistar albino 
rats exposed to Kalladaippu Thool for 90 days 
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Chart 16: The mean value of Neutrophils and Lymphocytes of control and treated 
groups of wistar albino rats exposed to Kalladaippu Thool for 90 days 
 
Chart 17: The mean value of Monocytes and Eosinophils of control and treated groups 
of wistar albino rats exposed to Kalladaippu Thool for 90 days 
 
 
0
10
20
30
40
50
60
70
80
90
100
Control Low dose Mid dose High dose
Neutrophils
Lymphocytes
0
0.05
0.1
0.15
0.2
0.25
Control Low dose Mid dose High dose
Monocytes
Eosinophils
108 
 
Chart 18: The mean value of PCV, MCHC, MCV, and MCH of control and treated 
groups of wistar albino rats exposed to Kalladaippu Thool for 90 days 
 
 
Table 21: Blood sugar test of Wistar albino rats group exposed to Kalladaippu Thoolfor 
90 days 
PARAMETERS CONTROL LOW 
DOSE 
MID 
DOSE 
HIGH 
DOSE 
P Value 
(p)* 
Bl.sugar (mg/dl) 
  
 90.30±8 89.5±6.28 91.6±16.1 91.89±20.9       N.S. 
 
N.S- Not Significant, **(p < 0.01), *(p <0.05), n = 6 values are mean ± S.D (One way 
ANOVA followed by Dunnett‟s test). 
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Chart 19:The mean value of Blood sugar of control and treated groups of wistar  
albino rats exposed toKalladaippu Thoolfor 90 days 
 
 
Table 22: Lipid profile test of Wistar albino rats group exposed to Kalladaippu Thoolfor 
90 days 
PARAMETERS CONTROL LOW DOSE MID DOSE HIGH DOSE P Value 
(p)* 
Sr.TC(mg/dl) 108.±8.3 114.83±12.93 115.6±8.28 112.83±6.76       N.S 
Sr.TG(mg/dl) 129.83±2.4 136.55±9.35 4132.5±9.73 136.5±9.31       N.S 
 
N.S- Not Significant, **(p < 0.01), *(p <0.05), n = 6 values are mean ± S.D (One way 
ANOVA followed by Dunnett‟s test) 
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Chart 20:The mean value of Sr.T.Cholesterol, Sr.Triglyceride of control and treated 
groups of wistar albino rats exposed toKalladaippu Thool for 90 days 
 
 
Table 23: Liver Function Test of Wistar albino rats group exposed to Kalladaippu 
Thoolfor 90 days 
PARAMETERS CONTROL LOW DOSE MID DOSE HIGH DOSE P 
Value 
(p)* 
T. Bilirubin(mg/dl) 0.86±0.04 0.79±0.1 0.75±0.1 0.80±0.13 N.S 
SGOT(IU/L) 21.6±5.08 22.5±9.97 27.6±9.09 26.15±2.04 N.S 
SGPT(IU/L) 27±5.9 30.8±5.45 28.5±3.72 31.57±10.9 N.S 
ALP (IU/L) 82.83±17.56 79.8±12.09 79±15.7 75.3±17.84 N.S 
T.Protein (g/dl) 6.7±0.48 6.5±0.28 6.6±0.84 6.8±0.75 N.S 
Albumin 3.9±0.57 3.6±0.67 3.6±0.59 3.4±0.36 N.S 
NS- Not Significant, ** (p < 0.01), * (p <0.05), n = 6 values are mean ± S.D (One way 
ANOVA followed by Dunnett‟s test) 
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Chart 21: - The mean value of T. Bilirubin of control and treated groups of wistar 
albino rats exposed to Kalladaippu Thoolfor 90 days 
 
 
Chart 22:The mean value of SGOT, SGPT and ALP of control and treated groups of 
wistar albino rats exposed to Kalladaippu Thoolfor 90 days 
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Chart 23:The mean value of T. Protein and Albumin control and treated groups of 
wistar albino rats exposed to Kalladaippu Thoolfor 90 days 
 
 
Table 24: Renal Function Test of Wistar albino rats exposed toKalladaippu Thoolfor 90 
days 
Parameters Control Low dose Mid dose High dose 
Urea (mg/dl) 32 30.16 28.3 26.5 
Creatinine 
(mg/dl) 
0.48 0.5 0.51 0.53 
Blood Urea 
Nitrogen 
(mg/dl) 
20.01±0.82 19.78±0.34 19.12±0.67 18.03±0.73 
NS- Not Significant, ** (p < 0.01), * (p <0.05), n = 6 values are mean ± S.D (One way 
ANOVA followed by Dunnett‟s test) 
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Chart 24: The mean value of Urea and Blood Urea Nitrogen of control and treated 
groups of wistar albino rats exposed to Kalladaippu Thoolfor 90 days 
 
 
Chart 25:The mean value of Creatinine of control and treated groups of wistar albino 
rats exposed to Kalladaippu Thoolfor 90 days 
 
0
5
10
15
20
25
30
35
Control Low dose Mid dose High dose
Urea
BUN
0.45
0.46
0.47
0.48
0.49
0.5
0.51
0.52
0.53
0.54
Control Low dose Mid dose High dose
Creatinine 
114 
 
HISTOPATHOLOGICAL EXAMINATION 
90-Days repeated dose oral toxicity study of Kalladaippu Thool 
BRAIN 
Control     High dose  
  
HEART 
ControlHigh dose 
 
  
KIDNEY 
Control High dose 
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 LIVER 
 Control      High dose 
   
     SPLEEN 
        Control     High dose 
   
Interpretation: 
 
The above slides show the histopathology studies of sub-chronic toxicity. There is no 
toxicological abnormality seen in the vital organs after administration of the test drug 
Kalladaippu Thool .Thus the safety of the drug is revealed so that it can be administered for 
long time without any side effects. 
 
Results of 90 days repeated dose oral toxicity study: 
Repeated dose 90 days oral toxicity study of Kalladaippu Thoolon rats were 
conducted. All animals from the treated dose survived throughout the dosing period of 90 
days. No abnormal behavioural signs were observed during the study period. 
The result of the body weight of rats exposed to control and the trial drug of different 
dose groups exhibited over all mild weight gain throughout the dosing period of 90 days. 
116 
 
The hematological and bio chemical investigations were conducted on 91
st
 day after 
the repeated dose of the drug revealed there are no significant changes in the values of 
different parameters with that of the control. 
Histopathological study of the organ such as brain, heart, kidney, liver and spleen 
were normal in control and test groups. 
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PHARMACOLOGICAL ACTIVITY 
Anti-Urolithiatic Activity of Kalladaippu Thool 
Table 25: Estimation of urinary electrolytes of normal and urolithiatic rats. 
Groups Oxalate(mg/dl) Calcium(mg/dl) Phosphate(mg/dl) 
I Control 0.34±0.02 2.916±0.170 3.64±0.04 
II Lithiatic control 2.10±0.08 8.150±0.33 7.29±0.06 
III Standard 
(Cystone 750 mg/kg) 
1.00±0.05** 3.916±0.250** 3.81±0.09** 
IV KT- 100mg/kg 0.616±0.06* 2.966±0.128* 4.24±0.10* 
V KT- 200 mg/kg 0.350±0.04** 2.983±0.185** 4.14±0.09** 
VI KT- 400mg/kg 0.450±0.04** 3.00±0.146** 4.01±0.06** 
The results were expressed as mean±SEM (n=6). Statistical analysis was performed by 
ANOVA test for multiple comparisons followed by Dunnett‟s test and P<0.05 was 
considered as significant. 
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Chart: 26 Estimation of urinary electrolytes of normal and urolithiatic rats 
 
 
Table 26: Estimation of Kidney Serum Electrolytes of Normal and Urolithiatic Rats 
Groups BUN(mg/dl) Creatinine(mg/dl) Uric acid(mg/dl) 
I Control 16.369±0.30 0.721±0.01 5.80±0.12 
II Lithiatic control 25.098±0.24 0.855±0.01 7.866±0.25 
III Standard 
(Cystone 750 mg/kg) 
21.398±0.39*** 0.981±0.006*** 5.033±0.08*** 
IV KT- 100mg/kg 33.328±0.73* 1.146±0.01* 6.533±0.14* 
V KT- 200 mg/kg 28.328±0.60*** 1.058±0.01*** 7.233±0.08*** 
VI KT- 400mg/kg 27.588±0.71*** 1.038±0.005*** 8.116±0.10*** 
 
The results were expressed as mean±SEM (n=6). Statistical analysis was performed by 
ANOVA test for multiple comparisons followed by Dunnett‟s test and P<0.05 was 
considered as significant. 
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Chart 27: Estimation of Kidney Serum Electrolytes of Normal and Urolithiatic Rats 
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HISTOPATHLOGY EXAMINATION OF ANTI-UROLITHIATIC ACTIVITY 
 
(a). Control group, 
(b). Ethyl glycol treated group, 
(c). ethylene glycol + Cystone treated (750 mg/kg) , 
(d). ethylene glycol + KT treated (100 mg/kg), 
(e). ethylene glycol + KT treated (200 mg/kg), 
(f). ethylene glycol + KTtreated (400 mg/kg), 
 
Results and Discussion: 
 The chronic administration of 0.75%v/v ethyleneglycol aqueous solution to male rats 
resulted in hyperoxaluria. Results of study were represented in Table – 25, 26. It shows the 
urinary excreted values of calcium, Oxalate and phosphate were significantly (P<0.01) 
increased in 200mg/kg and 400 mg/kg of KT doses when compared to the control group and 
also the values of blood urea nitrogen, uric acid, creatinine in serum were significantly 
decreased 200mg/kg and 400 mg/kg of KT doses when compared to the control group. 
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Diuretic Activity and Saluretic Activity of Kalladaippu Thool 
 
Table 27: Effect of Kalladaippu Thool on urinary volume in Wistar albino rats at 24h 
interval. 
 
Group Treatment and Doses Urine 
volume(mL) 
Diuretic 
 action
a
 
Diuretic 
activity
b
 
I Control 4.67±0.51 1.00 - 
II Furosemide(200 mg/kg) 8.90±0.45*** 1.91 1.00 
III KT (100 mg/kg) 6.67±0.19* 1.43 0.75 
IV KT (200 mg/kg) 8.03±0.45*** 1.72 0.90 
V KT (400 mg/kg) 10.17±0.95*** 2.18 1.14 
 
Values are expressed as mean ± SEM.n=6; 
a
Diuretic action - urine volume of test group / urine volume of control group. 
b
Diuretic activity - urine volume of test group / urine volume of control group. 
*
Significant change at P< 0.05 with respect to control rats. 
 
Chart 28: Effect of Kalladaippu Thool on urinary volume in Wistar albino rats at 24h 
interval. 
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Table 28: Effect of Kalladaippu Thool on urinary electrolyte excretion of Wistar albino 
ratsat 24 h urine sample collection 
 
Gro 
up 
Treatment and 
Doses 
Sodium 
(mMol/L) 
Pottassium 
(mMol/L) 
Chloride 
(mMol/L) 
I Control 110.14±9.12 58.49 ± 4.74 78.46± 4.29 
II Furosemide(200 
mg/kg) 
196.48±12.5*** 119.84± 14.27*** 141.75 ± 7.97*** 
III KT (100 mg/kg) 141.29 ± 5.47* 75.38± 3.10* 87.11± 6.72* 
IV KT (200 mg/kg) 160.25± 6.12*** 86.73 ± 3.70*** 100.97± 4.99*** 
V KT (400 mg/kg) 185.78±17.12*** 104.91± 6.23*** 114.89±5.43*** 
 
Values are expressed as mean ± SEM, n=6; 
 Index = excretion in test group/excretion in control group.  
Significant changes at P<0.05 with respect to control rats. 
 
 
 
Chart 29: Kalladaippu Thool on urinary electrolyte excretion of Wistar albino 24 h 
urine sample collection 
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Table 29: Effect of Kalladaippu Thool on Saluretic effect and Natriuretic effect of 
Wistar albino rats at 24h of urine sample collection. 
 
Group Treatment  Doses Saluretic effect 
(Na+Cl) 
Natriuretic 
effect 
(Na/k) 
Saluretic 
index 
Natriuretic 
 index 
I Control 188.60 ±10.75 1.98 ± 0.28 1.00  
II Furosemide(200 mg/kg) 338.23 ± 13.15*** 1.79 ± 0.25 1.79 0.90 
III KT (100 mg/kg) 228.40 ± 10.09* 1.91 ± 0.15 1.21 0.96 
IV KT (200 mg/kg) 261.22 ± 1.31*** 1.85 ± 0.04 1.37 0.93 
V KT (400 mg/kg) 300.68 ± 16.15*** 1.81 ± 0.20 1.59 0.91 
 
Interpretation: 
Results of study were represented in Table: 28 - 29. They show the values of urinary 
volume and urinary electrolytes. The drug administrated groups showed significant increase 
in urinary output compared to Control. 
Table -31, it explains the Saluretic effect of KT .The drug administrated group 
showed increased urinary sodium potassium and chloride levels compared to control groups. 
Significant differences were observed between standard and KT treated groups (Group IV, 
Group V) in excretion of urinary electrolytes. It has significant saluretic effect.The values 
greater than 2.0 indicate favourable natriuretic effect. As per that it has no natriuretric effect. 
When compared to lipscitz value of Kalladaippu Thooltreated groups between 1- 1.50 
as shown inTable-27, so it is considered as moderate Diuretic. 
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8. DISCUSSION 
The drug Kalladaippu Thoolwas selected from the Siddha literature“Anuboga 
vaidhiya navaneetham”to validate the safety and its efficacy in the evaluation of Anti-
Urolithiatic activity in ethylene glycol induced urolithiasis in Wistar albino rat model. 
  Various analyses such as physicochemical, chemical analysis were made. From the 
above analysis we came to know that the presences of active ingredients were responsible for 
its activity. Chemical analysis showed the presence of sulphate, iron and calcium. XRD 
analysis showed the presence of natroxlate, sodium chloride, sodium boron, potassium 
carbonate, potassium sulphide and boron carbide.Thus from these results we came to know 
that the effectiveness of the drug is due to the presence of these constituents and it has a 
synergistic effect in acting against the disease. 
 Toxicological studies of acute, sub-acute and sub chronic toxicity study were carried 
out in Wistar albino rat model according to the OECD guidelines. The test drug showed there 
was no mortality seen.  
The pharmacological study was carried out in Wistar albino rat model. Three 
activities were seen in the drug Kalladaippu Thool.The activities were 
 
 Anti-Urolithiatic activity     
 Diuretic activity                     
 Saluretic activity 
 
            Anti-Urolithiatic activity was carried out in Ethylene glycol inducedurolithiasis in 
Wistar albino rat model. The test drug Kalladaippu Thoolat the dose level of 200mg/kg and 
400mg/kg b.wt exhibits significant lowering of the elevated levels of calcium, oxalate, 
phosphate, urea nitrogen, creatinine and uric acid excretion in urine samples. Thus this 
activity reveals the effect of the drug against Urolithiasis. 
The Diuretic potential of Kalladaippu Thoolwas carried outin Wisteralbino rats 
withcomparison of control group. Test drug treated rats produced significant increase in urine 
output and electrolyte excretion in a dose-dependent manner when compared to control 
group. Furosemide and Kalladaippu Thool increase the urine flow significantly at 24 h when 
compared with control rats. The high dose excreted more than two fold the volume of urine 
as compared to control. The diuretic activity of the drug is considered nil if it is >0.72, little if 
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it is between 0.72 and 1.0, moderate if it is within 1.00-1.50 and good if it is above 1.50. In 
this respect, Kalladaippu Thool exhibits moderate diuretic activity. The diuretic responses 
with its electrolyte excretion potency of the Kalladaippu Thool where highly moderate in 
comparison to normal control rats. The Kalladaippu Thool at doses of 200 and 400 mg/kg 
showed a significant increasing sodium, potassium, and chloride excretion. Therefore the 
Kalladaippu Thool has been shown to possess significant saluretic effects. Thus the diuretic 
activity and saluretic activity of the drug is justified. 
 
 Thus by scrutinizing all the above mentioned factors it is concluded that the test drug 
Kalladaippu Thoolisa safe and a potent anti-urolithiatic drug. It alsopossesses rich diuretic 
and saluretic activity which supports the effective treatment for managing renal calculi and its 
complications. 
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9. SUMMARY 
 
 The test drug Kalladaippu Thoolwas selected from the siddha literature“Anuboga 
vaithiya navaneetham” for its Anti-urolithiatic, Diuretic and Saluretic  activites. 
 
 The test drug was prepared by the given procedure. All the ingredientswere identified 
and authenticated by the experts. 
 
 Review of literature in various categories was carried out Siddha aspect, botanical 
aspect disclosed about the drug and the disease.  
 
 The drug was subjected to analysis such as physicochemical, chemical and also 
instrumental analysis which provided the key ingredientspresent in the drug thus it 
accounts the efficacy of the drug 
 
 Toxicological study was made according to OECD guidelines comprising acute, sub-
acute and sub chronic toxicity study. It screens the safety of the drug whichattributes 
its utility in long time administration. 
 
 Pharmacological study was done. It revealed that the Anti-urolithiatic, Diuretic and 
Saluretic activities of Kalladaippu Thoolin Wistar albino rat model. 
 
 Results and discussion gives the proper justifications to prove the potency ofthe drug. 
 
 Conclusion gives a compiled form of the study and explains the synergistic effect of 
all the key ingredients and activities that supports the study. 
 
 Thus the herbo-mineral formulation Kalladaippu Thoolis validated for itssafety and 
efficacy for treating Kalladaippu and it would be a great drug ofchoice. 
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     10. CONCLUSION 
 
From the literature evidence, physicochemical analysis, chemical analysis, 
Toxicological evaluation and Pharmacological studies, the drug Kalladaippu Thool have anti-
urolithiatic, diuretic and saluretic activity. It was concluded that the Kalladaippu Thool can 
be used in the management of Kalladaippu (Urolithiasis). 
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